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This thesis reports research carried out to test the 
validity of using an interactional model to study medication 
compliance amongst manic depressive out-patients. 
A questionnaire was developed and administered to 
64 subjects. Interviews were subsequently conducted with 
the doctors of the subjects to confirm the information 
obtained from the questionnaires. 
A number of subject characteristics and/or attitudes 
were found to be more significant than others in determining 
compliance/noncompliance. Frequently these variables had 
to be combined before significant results emerged, indicating 
that compliance is determined primarily by an interrelationship 
of variables rather than simply by isolated variables. 
The results of the research provide strong support 
for the use of an interactional model in the study and 




Why do some individuals faithfully follow professional 
health care advice while others do not? This question has 
raised more problems than it has solved, with numerous reasons 
having been hypothesised in the process. 
Known otherwise as the problem of health care 
compliance it has been described as "one of the least under-
stood yet most guessed about topics in health care" (Haynes, 
1976, p.3). Here it forms the basis for the present review 
and study which focuses upon lithium compliance by manic 
depressives. 
Despite the existence of health care noncompliance 
for centuries, it has only recently become a popular topic 
for research with publications roughly doubling every five 
years between 1956 and 1975 (Blackwell, 1976). Increased 
interest in the early 1960s has been attributed to: 
1) greater recognition and availability of effective medical 
treatments, 2) a greater awareness of patients' rights, 
3) a decline in professional paternalism, 4) a closer analysis 
of drugs already available caused by a slowing down in the 
discovery of new drugs, and 5) increased interest in the 
benefits of long term prophylactic drug maintenance 
(Blackwell, 1976; Haynes, 1979a). 
Health care compliance behaviours are fundamental if 
effective treatment results are desired. With the exception 
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of very few instances, noncompliance generally produces 
negative medical and economical consequences for both the 
patient and health care system (Dracup & Meleis, 1982). 
Despite these adverse repercussions, noncompliant health 
behaviours are widespread. Reviews report average levels of 
noncompliance ranging from 15 to 50% with the occasional 
level as high as 90% of the individuals studied (M.S. Davis, 
1966; Jamison & Akiskal, 1983; Marston,1970; Sackett & 
Snow,1979; Stimpson,1974). 
Kasl (1975) categorised health care compliance 
behaviours into 4 categories: "a) entering into or continuing 
a treatment program, b) keeping follow-up or referral 
appointments, c) taking prescribed medication and d) restrict-
ing or changing one's activities including smoking, diet and 
exercise" (p.6). Due to the immensity of the literature 
published on health care compliance, per se, the review to 
follow will focus primarily on Kasl's third category, patient 
compliance with prescribed medication regimens. Where 
applicable the review will focus upon the compliance litera-
ture associated with lithium carbonate and manic depression, 
in preparation for the study to follow. 
More comprehensive reviews and annotated bibliogra-
phies covering a more extensive study of health care 
compliance are available for those who may be interested 
(Barofsky,1977; Blackwell,1982; Eraker, Kirscht & Becker, 
1984; Evans & Spelman,1983; Haynes,Taylor & Sackett, 1979; 





Lack of patient compliance with recommended health 
regimens is recognised as a major complicating factor within 
the medical profession (Blackwel~ 1976). Keeping in mind 
the potentially detrimental implications and influence of 
this behavioural problem, the present chapter reviews the 
definition, history, extent of the problem, methods used 
for measuring compliance, and the determinants and theoretical 
approaches associated with compliance research. Finally 
there will be a brief description of the purpose behind the 
choice of topic chosen for the compliance study outlined. 
2.1 COMPLIANCE AND ADHERENCE DEFINED 
Patient co-operation, adherence, acceptance, participa-
tion and therapeutic alliance are but a few of the terms used 
to represent patient compliance. These terms convey positive 
connotations while other terms such as refusal, disobedience, 
abuse, deviation and default, convey more negative connota-
tions. Unfortunately a review of past literature indicates 
a great deal of confusion about the term compliance with many 
alternative terms being used inconsistently (Linden,1981). 
This review and study will use the terms compliance 
and adherence interchangeably to refer to "the extent to 
which a person's behaviour (in terms of taking medications, 
following diets, or executing lifestyle changes), coincides 
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with medical or health advice" (Haynes, 1979a, p.l). 
This is becoming a commonly used definition in recent 
compliance literature and hopefully indicates an increasing 
trend towards the standardisation of terms and measurements. 
The definition as originally intended is nonjudgemental. 
Blackwell (1976) further categorised medication non-
compliance into four types of errors: 1) errors of omission, 
where the individual fails to fill the prescription, or 
having done so fails to take the drug; 2) errors of dosage; 
3) errors of purpose, where t_he individual takes the medica-
tion for the wrong reasons; and 4) mistakes in timing or 
sequence. 
2.2 HISTORY 
The phenomenon of patient noncompliance with health 
care advice was documented as far back as 20 centuries ago 
when Hippocrates wrote, "Ithe physician] should keep aware 
of the fact that patients often lie when they state that 
they have taken certain medicines" (as quoted by Haynes, 
1979a, p.3}. The issue gained little further attention 
until the early 1960s when research into patient compliance 
increased dramatically. This culminated in the publication 
of two major comprehensive reviews and references on the 
topic by Sackett and his colleagues - 'Compliance with 
Therapeutic Regimens' (Sackett & Haynes, 1976) 
and 'Compliance in Health Care' (Haynes et al, 1979). 
The increased attention presently being given to 
compliance is consistent with current trends in medicine. 
These indicate an increase in lifestyle diseases - primarily 
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resulting from neglect of our bodies, e.g. heart disease, 
cancer and strokes; and the decrease of infectious-type 
illnesses, e.g. diptheria, smallpox and bacterial pneumonia 
(Jay, Litt & Durant, 1984). 
2.3 THE EXTENT OF THE NONCOMPLIANCE PROBLEM 
Although our understanding of the problem is limited 
there is no doubt about the existence of patient noncompliance. 
Reviews of numerous studies report noncompliance rates of 
between 16% and 90% with health care appointments; 22% and 
40% with prescribed short term medications, and 6% and 67% 
with prescribed long term medications (Becker & Maiman,1980; 
Blackwell 1973; Haynes, et al 1979; Van Putten 1975). 
Not only do problems arise for the noncompliant 
individual but other problems and increased pressures fall 
on the health care services. Outpatient visits and 
unnecessary hospitalisations increase, while doubts arise 
about the efficacy of treatments and therapies. Baastrup 
(as noted by Van Putten, 1975), for example suggests that up 
to 75% of all relapses among patients on lithium may be 
accounted for by negligence. Subsequently more time, energy 
and money is wasted in futile searches for more 'effective' 
treatments while the problem itself lies unresolved with 
the patient. Stason and Weinstein (1976) recognised this 
problem and proposed that a greater allocation of funds spent 
on improving adherence to antihypertensive regimens would 
reduce disability and/or death resulting from hypertension 
to a greater extent than the same expenditure used in the 
detection and treatment of new cases of hypertension. 
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Compliance is also an extremely important but often 
overlooked variable in clinical outcome studies where the 
effectiveness of various treatments are compared and 
contrasted (Feinstein, 1979; Lipman, Rickels, 
Uhlenhuth, Park & Fisher,1965). 
Noncompliance then is a widespread problem which 
results in the inefficient use of health care services. 
When unidentified it has the potential to call into serious 
question the efficacy of otherwise effective clinical 
therapies and treatments. 
A survey of the lithium literature indicates that 
noncompliance ranges from 20 to 52%, consistent with non-
compliant levels found in studies of other long term medica-
tions. Of six studies reviewed by Van Putten (1975), non-
compliance ranged between 20 and 30%. Since then Jamison, 
Gerner and Goodwin (1979) have reported 47% of individuals 
on lithium stopping it at least once against medical advice, 
while Kucera-Bozarth, Beck & Lyss (1982) reported 52% of 33 
individuals on lithium (not all manic depressives), non-
compliant with their medication. 
2.4 METHODS FOR MEASURING COMPLIANCE 
Medication compliance can be assessed using either 
direct and/or indirect methods. Direct methods involve the 
identification of the drug in the blood or urine of the 
patient. In contrast, indirect methods involve assessments 
by either the patient or other significant people, pill 
counts or outcome assessments to help determine whether or 
not the individual has taken his medication. 
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Major difficulties arise when interpreting compliance 
data and especially when comparing compliance studies because 
of differences in the operational definitions of compliance 
across studies (Evans & Spelman, 1983). Some differences 
reflect the variety of behaviours under study, e.g. compliance 
with medication as against compliance with diets or exercise. 
Other differences, however, result from the use of different 
methods and standards when measuring compliance of the same 
behaviour. Direct and indirect measurements of medication 
compliance for example will frequently produce different 
results. Direct measures are generally acknowledged to 
produce higher noncompliance figures than indirect measures, 
but as Blackwell (1976) proposes, "none of the methods of 
detecting or studying nonadherence are without shortcomings 
or difficulties" (p.516). 
The section to follow investigates the variety of 
techniques used to measure compliance with medication, 
including a brief discussion of the various methodological 
problems present in each. 
2.4.l Direct Measures of Compliance 
The shortcomings present with all direct measures of 
compliance, by their very nature are similar, and so will be 
discussed at length after a short description of each type of 
measure. 
2.4.1.1 Blood ~evel Monitoring 
The concentration of a drug or its metabolites in the 
blood is used as an indication of the ingestion of a specific 
medication by an individual. This technique is especially 
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useful for estimating dosage consumed when a clear relation-
ship exists between the medication dosage and a steady state 
blood level. When substances are difficult to identify in 
the blood, marker compounds may be added to the medication 
to assist with its monitoring. 
Blood level monitoring of lithium levels became 
popular with the development of adequate serum lithium 
monitoring techniques around 1952 (Coombs, Coombs & 
Mee,1975). Although the relationship between medication 
dosage and blood lithium levels is not clear using this 
method, its usefulness increases with the demonstration of 
a definite relationship between lithium levels and the 
nature of the clinical response - namely the onset of side 
effects and toxic reactions (Johnson & Cade, 1975). It is 
important to remember with respect to lithium management, 
that it is not the dosage but the lithium blood level which 
matters, so that what might be a therapeutically inadequate 
dose for one person may be potentially lethal for another. 
2.4.1.2 Measurement of Urine Excretion 
Techniques have also been developed which identify 
certain drugs in an individual's urine. Once again this 
involves identification of either the drug itself, its 
metabolic by-products or marker compounds. The measurements 
are then used to identify compliance. 
The presence of lithium in urine can also be measured 
using the same apparatus as that used with blood level 
monitoring. Unfortunately urine lithium estimates are 
reported to be less accurate than serum levels. This is 
due to greater variations in urine concentrations amongst 
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people which ultimately affects the final lithium measurement. 
Consequently serum lithium levels are a preferable lithium 
measurement to urine lithium estimates (Amdisen,1975). 
2.4.1.3 Other Methods 
Other direct methods of measuring compliance have 
included an attempt to detect medication tracers in the 
stools of psychiatric patients (Blackwell, 1976), the develop-
ment of a breath test to identify certain medications, e.g. 
disulfiram (Masur, 1981), and the development of techniques 
to identify certain medication in saliva (Jay et al 1984). 
The latter method has also been used in a variety of 
experimental analyses of lithium which have included 
analyses of capillary blood samples, erythrocytes, 
cerebrospinal fluid and the tissue of normal body organs. 
Since each of these methods has only been tested once or 
twice it would be premature to make any general conclusions 
other than to say there is still more room for research 
(Coombs et al, 1975). 
2.4.1.4 Problems and Limitations of Direct }ieasures of 
Compliance 
Blood level and urine excretion tests are regarded as 
two of the most objective procedures used for measuring 
patient compliance with medication. The accuracy of these 
methods however is affected by a number of factors. These 
include: 1) pharmacokinetic variations, 2) the period of 
time the individual has been using the medication and 3) 
the effect of repeated measures upon compliance. 
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1. Pharmacokinetic Variations 
This refers to the individual differences which occur 
in the absorption, distribution, metabolism and excretion 
rates of different medications. This in turn is affected 
by the different rates of absorption according to the 
formulation of the drug, with syrup forms being absorbed 
much faster than coated tablets (Gordis,1979). Lithium 
for example comes in two different preparations, the first 
of which is available as a tablet of 250 mg of lithium. 
The second preparation is a sustained release tablet 
equivalent to 400 mg of lithium which is released slowly 
over a period of several hours (Martindale, 1972). The 
absorption of medication is subsequently affected by inter-
actions with other medication, interferences by food and 
individual genetic differences in the metabolism and 
excretion of medication. 
A review of the literature by Gordis (1979) indicated 
that genetic determinants played an important part in the 
metabolism of drugs, graphically illustrating the vast 
individual differences which occurred within the studies 
reviewed. 
Of equal importance is the excretion pattern of the 
drug, metabolite or tracer being detected. A positive test 
will indicate that the medication has been ingested within 
the excretion time range but does not guarantee anything 
about,before or after this interval. In contrast a negative 
test may simply indicate that the drug has been rapidly 
excreted and therefore can no longer be detected. 
With respect to lithium the literature reports that 
lithium is readily absorbed when administered orally and peak 
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plasma concentrations occur two to four hours after 
ingestion (Martindale,1972). A further review of the 
literature exposed two case studies of noncompliant manic 
depressives on lithium who just prior to their scheduled 
serum lithium levels consumed unusually large quantities of 
lithium, making them appear faithfully compliant (Schwarcz, 
1980). Keeping this in mind it seriously undermines the 
use of serum lithium levels as an accurate measurement of 
compliance. 
To overcome this problem Schwarcz (1980) proposed 
that spot lithium checks should be used more regularly. 
Gengo, Frazer, Ramsey, and Mendels (1980) are also aware of 
this problem but suggest instead that the measurement of the 
erythrocyte concentration of lithium may improve the accuracy 
of assessment. Having also been tried by Frazer et al (1978), 
the results of both studies are encouraging and indicate a 
possible solution to the problem. Using this measurement 
lithium would have to be taken for 3 or 4 consecutive days 
prior to testing for the lithium ratio to be at a steady 
state. 
The above-mentioned problems with lithium highlight 
the need to examine carefully the various pharmacokinetic 
characteristics of any medication under investigation when 
assessing patient compliance. Failure to do so may otherwise 
affect compliance rates by inadvertently lowering the drug 
analysed and incorrectly assessing compliance. For these 
reasons Biggs, Chang, Sherman & Holland (1976) seriously 
question the value of using direct measures to determine 
the degree of compliance. They also emphasise that in the 
majority of studies to date which have incorporated direct 
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measures, it has not always been clear whether it has been 
the variations in compliance or variations in the 
bioavailability of the drugs prescribed and taken, that 
have been identified. The caution expressed by Biggs and 
his colleagues is reiterated by Gordis (1979). He warns 
that the failure to consider pharmacokinetic variations 
associated with the patient and the drug preparation, could 
create serious errors in inference regarding compliance 
levels among different groups of patients. 
2. Period of Time Using Medication 
In a review of various studies, Gordis (1979) found 
that depending upon the particular drug in question, the 
period of time an individual has been using the medication 
can affect the metabolism of it. The metabolism of some 
drugs therefore will be enhanced the longer' an individual 
has been using it, substantially decreasing the blood level 
of the drug. However, for other drugs the metabolism is 
inhibited the longer it is taken, increasing blood levels 
of the main compound. 
Very little has been reported about the effect of 
time spent on lithium in relation to metabolic rate. 
Johnson and Vacaflor (1975) however, reviewed two articles 
which suggest that the weight gain reported by many individuals 
on lithium may be attributable to a decrease in overall 
metabolic rate secondary to reduced thyroid functioning. 
If this is the case one might expect that serum lithium 
levels would increase the longer it is prescribed. 
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3. Repeated Direct Measures 
The effect of repeated direct measures on compliance 
measurements has become more and more controversial with the 
increased interest shown in compliance studies. Some 
researchers encourage the use of repeated measures for 
methodological reasons while others doubt its practical 
usefulness because of reactive effects it may have on 
compliance levels. 
Blackwell discourages the use of isolated spot checks, 
but admits that, "unlike the placebo response, which 
increases with attention paid to people, poor adherence tends 
to disappear under scrutiny" (Blackwell, 1976, p.514). 
Other researchers believe that although theoretically, 
repeated measures should provide a more reliable and valid 
measurement, in fact they inadvertently give a false indica-
tion of the level of compliance by temporarily increasing 
it (Evans & Spelman,l983; Marston,l970). 
These opinions reflect the confused findings of a 
variety of studies investigating the effect of repeated 
direct measures on compliance. Some report that compliance 
measurements inferred from urine specimens collected during 
unannounced home visits correlate well with those obtained 
at the time of clinic visits (Gordis, Markowitz & Lilenfeld, 
1969a). Meanwhile others report that noncompliance is higher 
for specimens collected in unannounced home visits than those 
collected at clinic visits (Marrow & Rabin, 1966). On the 
other hand Maddock (1967) found no difference in the propor-
tion of negative tests for specimens collected either in the 
clinic or during unannounced home visits. 
Direct measures are also subject to the problems 
which arise when comparing compliance studies. Some 
investigators will estimate compliance from the results 
of one blood or urine specimen while others will base 
their estimates on repeated measures. Then with studies 
of repeated measures the operational definitions of 
compliance will differ according to the varying portions 
of positive or negative test results obtained. 
14 
Frequently when single tests are used there is a 
tendency for the classification of individuals to be 
dichotomous, either complier or noncomplier, with no 
gradations. When multiple tests are used, one can define 
various levels of compliance, which some studies have 
shown may vary throughout the course of treatment (Gordis & 
Markowitz, 1971). 
To conclude this section on direct measures, although 
they appear to be more methodologically sound and ultimately 
more favourable because of their objective nature, many of 
the issues discussed previously are unacknowledged or simply 
not discussed in studies using these measures. Consequently 
care should be taken when interpreting or comparing studies 
using only direct measures of compliance. 
2.4.2 Indirect Measures of Compliance 
2.4.2.1 Therapeutic Outcome 
Assuming the medication is effective, some studies 
have used the degree of improvement in a patient's condition 
as an indication of whether or not the individual has been 
compliant with his or her medication (Markowitz,1970). 
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Acceptance of this technique assumes that improved patient 
outcome is mediated only through compliance with the 
specified medication regimen. It overlooks the influence of 
extraneous variables, i.e. spontaneous remissions, multiple 
treatments, socioeconomic or cultural factors upon improve-
ment, not to mention that total compliance does not 
necessarily guarantee treatment success. Individuals may 
also be the victims of an inaccurate diagnosis which this 
method does not allow for (Gordis, 1979; Sackett, 1976). 
Except for behavioural interventions where treatment 
effects can be manipulated through ABA reversal designs, 
therapeutic outcome is not considered a valid or reliable 
independent measure of patient compliance (Sackett,1976b). 
However, used in combination with other measurements, it 
may enhance the validity of the compliance measurement. 
Despite its inadequacies as a research technique, 
therapeutic outcome can be useful in clinical settings 
where it may be impractical to assess the compliance of all 
patients in any other way. Assessments could then be 
directed more efficiently and appropriately towards those 
who fail to reach the therapeutic goal (Gordis,1979). 
A similar measure to therapeutic outcome is that of 
noting the presence or absence of side effects which occur 
consistently with some drugs. The disadvantages of this 
technique are similar to those of therapeutic outcome. In 
addition it overlooks unreliable reporting of side effects 
by patients (Evans & Spelman, 1984). 
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2.4.2.2 Patient Self-Report 
Patient self-report basically involves asking either 
directly or indirectly, whether or not patients have been 
complying with their medication. 
A number of studies evaluating medication compliance 
have attempted to document the accuracy of interview data 
by comparing it with more objective measures. A review of 
the literature indicates discrepancies ranging from 8 - 36% 
when self-report has been compared with urine measurements 
and pill counts (Feinstein et al, 1959; Gordis, Markowitz 
& Lilienfeld, 1969b; Park & Lipman, 1964; Wilcox, Gillan 
& Hare, 1965). The discrepancy in each case pointed towards 
an overestimation of compliance by self-report. 
When questioning patients about their compliance, 
if asked in a nonthreatening nonjudgemental manner, it is 
thought about half the noncompliant patients will admit to 
missing at least some of their medication (Jay et al, 1984). 
It is estimated that of those who confess to missing 
medication, on average they will overestimate the extent of 
their compliance by about 20% (Haynes, 1982). 
While a discrepancy exists between self-reports of 
compliance and other measures, a close correspondence has 
been found between self-reports of noncompliance and some 
measures (Feinstein et al, 1959; Park & Lipman, 1964). 
There is little evidence of compliers misrepresenting them-
selves as noncompliers, although Kucera-Bozarth et al (1982) 
reported that 9% of a sample of 37 reported themselves as 
noncompliant when lithium levels suggested they were 
compliant. Nevertheless the major problem with self-report 
would seem to be correctly identifying the noncompliant 
patient who claims to have complied (Gordis, 1976). 
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Used prior to the implementation of intervention 
strategies for improving compliance, self-report was a 
useful technique for indicating success. Sackett (1976b) 
found the only patients who responded favourably to efforts 
to improve compliance were those who initially admitted to 
being noncompliant. 
2.4.2.3 Assessment of Compliance by Significant Others 
Mothers, relatives, doctors and nurses have all been 
studied by researchers to determine how accurately they can 
assess medication compliance by someone they have contact 
with either personally or professionally. 
A review by Gordis et al (1969a) reported that when 
mothers' assessments of their children's compliance with 
prescribed penicillin were compared with urine measures, 
numerous discrepancies were found. These discrepancies 
ranged from 14 - 31% with each assessment overestimating 
compliance. Meanwhile another study assessing the degree to 
which mothers followed through on doctor's advice, primarily 
on the basis of responses to interviews, found only 11 
discrepancies out of 129 instances where pill counts were 
compared with the interview assessments. In all 11 instances 
the pill count indicated noncompliance while the interview 
implied compliance. Although encouraging, the interpreta-
tion of these results is limited by the selection of the 
individuals involved. 
Relatives are often unable to accurately rate the 
degree of medication compliance by an individual. Some 
genuinely do not know, while others possibly responsible for 
the noncompliant medication administration are not willing 
to admit it (Evans & Spelman 1984). Asking relatives is 
therefore considered unreliable. 
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Despite doctors' increased awareness of the problem 
of noncompliance, their ability to detect it is very 
unreliable (M.S. Davis, 1966). Studies indicate that the 
more senior the doctor, the more likely he or she will be 
to overestimate compliance in his/her patients. Meanwhile 
junior doctors, although more accurate have no more than a 
50% chance of identifying noncompliance (Caron & Roth, 1968; 
Gordis, 1979; Mushlin and Appel, 1977). Haynes (1979b) 
proposed that the inability of the doctors to identify 
noncompliance was in line with conclusions from various 
studies that there were no readily observable characteristics 
of patients with poor compliance that allowed their easy 
identification. Other studies which support the inadequacy 
of doctors' assessments of compliance include: Charney 
(1972), Kasl (1975) and Paulson, Krause and Iber (1977). 
Nurses' assessments of compliance are also regarded 
as unreliable. This is largely due to the difficulty which 
exists for nurses in determining whether or not patients 
have actually swallowed their medication. Observations 
made by nurses in one study identified 1.7% of their 
patients were noncompliant whereas urine tests indicated 
7.9% of the same patients to be noncompliant (Ballinger, 
Ramsey & Stewart, 1975). 
2.4.2.4 Pill Counts 
Pill counts involve either counting the tablets 
left in one's bottle, measuring and/or weighing liquid 
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solutions or counting empty medication bottles. The amount 
of medication remaining is then compared with the amount that 
should be remaining and any discrepancies between the two 
are noted. Alternatively a check can be made of when 
patients return for a repeat of their medication in relation 
to the expected time. 
This measure of compliance makes the assumption that 
absent medication has been taken as prescribed. Failure to 
return medication however does not guarantee that it has 
been appropriately used by the patient. 
Opinions of researchers evaluating the adequacy of 
pill counts as a measurement technique reflect the inconsis-
tent findings of studies reviewed. Some researchers main-
tain that pill counts are no more accurate than self report 
with noncompliers either failing to bring their pills to be 
counted or altering the amount of medication in the 
container to reflect better than actual compliance 
(Blackwell, 1976; Jay et al, 1984). 
In contrast, other researchers feel more positive 
about the adequacy of pill counts. One study comparing 
bottle counts with blood bromide levels found a moderately 
high correlation of .8 between the two measures (Roth, Caron 
& Hsi, 1970). Similarly when urine tests were compared 
with pill counts amongst 19 patients taking imipramine it 
was found that only 3 patients had negative urine tests 
when pill counts indicated compliance (Porter, 1969). 
Finally Park and Lipman (1964), demonstrated that while 
15% of their patients reported noncompliance, a pill count 
identified a 51% deviation. 
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When Blackwell (1976) discriminated between 
compliance errors of omission and commission, he suggested 
that compliance problems could be more accurately identified 
using pill counts, by giving an individual a greater ampunt 
of medication than necessary. Compliance would then be 
assessed according to the amount of medication left in 
relation to the overall treatment regimen and the amount 
of medication originally dispensed. This method was used 
by Lipman et al (i965) during a clinical trial to determine 
the effectiveness of a certain drug. Unfortunately, despite 
the conclusion that 45.7% of the sample had taken 75% or 
less of the medication recommended, no mention was made of 
patients who may have taken more than the recommended 
amounts. 
Similar to other compliance measurements, pill 
counts are also susceptible to varying operational 
definitions of noncompliance. Just as investigators differ 
in their operational definitions of what proportion of 
negative excretion tests are necessary before defining 
noncompliance when using direct measures, so too do researchers 
using pill counts differ in the magnitude of pill count 
deviations permitted before defining noncompliance (Marston, 
197 0) . 
The validity of pill counts is weakened dramatically 
when the prescription medication is of a type that might be 
used by other family members, where leftover medication might 
be available to use instead, or when prescription drugs may 
be obtained from others. In line with these criticisms, a 
detailed review by Gordis concluded by seriously questioning 
the validity of pill counts as an indirect measure of 
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compliance (Gordis, 1979). 
2.4.2.5 Other Indirect Methods of Measurement 
2.4.2.5.1 Medication monitors 
Special medication monitors have been developed 
in an attempt to estimate pill taking practices as 
objectively as possible. They involve a specially prepared 
dispenser which holds individually wrapped and date labelled 
tablets stacked in sequence. Each pill wrapping is designed 
to trigger off the detection of radioactive sources within 
the dispenser itself. Consequently when the dispenser is 
returned, the researcher can determine whether or not the 
pills have been steadily removed at regular intervals, or 
whether multiple doses have been removed from the dispenser 
simultaneously (Moulding, 1971, 1979, as outlined by Masur, 
1981, p. 447). 
Apart from being very expensive, this method has the 
same problem as pill counts in that one cannot guarantee 
that the absent pills have been properly taken. 
2.4.3 Conclusion of Methods for Measuring Compliance 
Summarising this section, an important point to keep 
in mind is that all the methods used to operationally define 
and measure compliance as reviewed here have limitations and 
inadequacies. 
Direct methods including blood and urine measures, 
despite being the most objective procedures, have individual 
biological and genetic complications which interfere with 
the accuracy of assessment. Although they are factors which 
should be considered and made allowance for, they are 
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frequently unacknowledged in the majority of studies using 
these methods. 
Therapeutic outcome and the monitoring of side 
effects are two indirect measurement techniques neither of 
which are considered very reliable or valid for research 
purposes. Nevertheless they are both considered useful for 
practical purposes in the clinical settings. 
Patient self-report and pill counts are both 
suspected of overestimating real compliance although are 
useful for identifying self-reporting noncompliers. 
Assessments by significant others have proven 
unreliable and also subject to many of the inadequacies of 
self-report. 
Other methods such as medication monitors have appeal 
but are disadvantaged by the factor of expense. More of 
the appeal is lost as one considers that despite its cost it 
does not guarantee to overcome the shortcomings of less 
expensive methods, i.e. pill counts. 
APPENDIX TO CONCLUSION 
After reviewing each method available for measuring 
compliance two major points seem significant. 
1. The problem of no standard operational definition 
for medication compliance. This is a complicated problem 
because the diversity of methods available for measuring 
compliance suggests it is unlikely one operational definition 
will ever dominate. Consequently one suspects that if 
research continues to progress in this area as it has done 
in the past, it may well necessitate subdivisions, defined 
by measuring techniques. This would enable standard 
operational definitions within groups to evolve enabling 
more meaningful comparisons between studies to occur. 
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2. The accuracy of the various methods of measurement. 
Despite the limitations present with the direct methods used 
for measuring compliance, throughout the reviews the reported 
accuracy and validity of all the indirect measurements have 
been estimated by comparing their results with those of the 
direct methods. Very few questions have ever been raised 
about the validity of the direct measures. It may well be 
appropriate to ask which measure is validating the other. 
2.5 MODELS AND THEORIES 
Over two hundred variables have been studied in an 
attempt to help identify and predict individuals who may 
become noncompliant. Two extensive reviews of the variables 
studied were undertaken by Becker et al (1979); Haynes 
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(1979b); Hulka (1979); and Jay et al (1984). In the review 
by Jay et al the variables investigated were categorised 
within three major theoretical approaches to health care 
compliance. An overview of these reviews will follow this 
structure outlining each major approach and summarising the 
most important conclusions. 
Unfortunately inconsistency of findings amongst 
studies was common and made the task of drawing conclusions 
difficult. 
2.5.1 Individualistic Models 
These models represent the most common approach to 
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the study of health care compliance. They assume that non-
compliant individuals possess unique characteristics that 
differentiate them from compliant individuals. Research 
based upon this assumption has attempted to identify such 
characteristics by noting individual factors that differen-
tiate compliant and noncompliant individuals. 
The approach incorporates what have otherwise been 
described as the medical model, control and learning 
theories (Dracup & Meleis, 1982). It focuses upon easily 
identifiable and quantifiable dimensions such as social, 
demographic and personality variables of the individual; the 
severity and duration of the disease; and the type, 
complexity, duration and discomfort of the prescribed 
regimen. 
The most important conclusions drawn from research 
using this approach are summarised below: 
1. Research has yielded an unsystematic mul tiplici t_y of 
findings that are frequently contradictory. 
2. Of over twenty sociodemographic variables tested only 
age, in particular the very young and very old, shows 
a predominantly positive association with noncompliance 
Although other factors have results indicative of 
positive and negative associations with compliance 
each have substantially more studies reporting no 
significant findings. 
3. With respect to disease related factors, mental 
disorders especially schizophrenia, paranoia and 
personality disorders tend to be negatively associated 
with compliance. 
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4. Increased symptomatology is negatively associated 
with compliance. 
5. Increased disability is positively associated with 
compliance. 
6. Parenteral drug administration,due to the direct 
nature of administration,is positively associated 
with compliance. 
7. The longer the duration of treatment the more negative 
the effect on compliance. 
8. The greater the number of medications and treatments 
prescribed, and ultimate cost,the greater the non-
compliance. 
9. The erring practice of some pharmacists who dispensed 
less medication than ordered was also negatively 
associated with compliance. 
10. The introduction of safety containers was negatively 
associated with compliance. 
(Eaynes, l979b; Jay et al, 1984; Masur, 1981) 
The major criticism with the individualistic approach 
is its predominant emphasis upon patient characteristics and 
failure to consider the possible interactions between 
behavioural, psychological, environmental, structural, 
physical and/or medical variables. 
2.5.2 Health Belief Model 
Another major model proposed for the analysis of 
compliance is the Health Belief Model (HBM). It is a 
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theoretical framework developed during the early 1950s to 
help explain the likelihood of an individual undertaking a 
recommended preventive health action. Having undergone 
numerous modifications, currently the theory postulates 
that health behaviour is a function of the individual's 
perceptions of: 
1) level of personal susceptibility to the 
particular illness or condition; 2) degree 
of severity of the consequences (organic 
and/or social) which might result from 
contracting the condition; 3) the health 
action's potential benefits or efficacy 
in preventing or reducing susceptibility 
and/or severity; 4) physical, psychological, 
financial, and other barriers or costs 
related to initiating or continuing the 
advocated behaviour. The HBM also stipulates 
that a cue to action or stimulus must occur 
to trigger the appropriate behaviour by 
making the individual consciously aware of 
his feelings about the health threat. 
(Becker et al, 1979, pp.78 and 81) 
The HBM has been successfully applied to many 
compliance studies although many have also found little 
merit in the model (Becker et al, 1979). Jay et al (1974) 
reviewed a number of studies according to the particular 
component of the model the findings related to. The most 
important conclusions drawn from this review are summarised 
below: 
1. Although a number of studies have found positive 
associations between patient's perceptions of their 
susceptibility to a particular disease and compliance with 
the prescribed medical advice, some studies have reported 
an inverse relationship. This raises questions about 
whether perceptions of susceptibility increase compliance, 
whether successful preventive health behaviours lower 
perceptions of susceptibility to disease, or both. 
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2. Data from research studying the relationship between 
perceptions of severity of illness and patient compliance 
with medical advice are inconsistent. Findings suggest 
that acceptance of medical advice and increased compliance 
can result from fear of a particular disease. However, 
very low or very high levels of perceived severity are 
unlikely to affect compliance. 
3. The majority of research investigating individual 
perceptions of the benefits of conforming with medical 
advice have reported a significantly positive relationship 
between faith in doctor and compliance. 
4. The perceived costs of compliance are many and 
level of compliance has been found to depend largely upon 
the perceived costs of compliance to each individual 
concerned. Costs may be financial, personal, health 
related, time related etc. 
Despite empirical support for some of the components 
of the HBM, several criticisms have been made about it: 
1. It overlooks the possibility that noncompliance may 
be unintentional, although this depends entirely upon how 
noncompliance is defined. 
2. The model does not specify how social agents or 
cues to action influence patient motivation, how they occur 
or why they may fail. 
3. Due to the subexperimental design of most studies 
the model is unclear about the causal nature of the link 
between health beliefs and compliance (Haynes, 1979b). 
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4. The degree of importance that health beliefs have 
on compliance over time are unexplained (Haynes, 1979b). 
5. Like the individualistic models the HBM places too 
much emphasis upon the individual and not enough on the 
doctor-patient interaction (Jay et al, 1984). 
2.5.3 Doctor-Patient Relationship 
The third approach that Jay et al (1984) refer to 
is that of the doctor-patient relationship. 
As noted from the previous literature reviewed, 
the tendency for both the individualistic models and health 
belief model to emphasise patient characteristics alone 
has been considered inadequate. This model was proposed 
to take into consideration the interaction of both the 
doctor and patient in their relationship together. Although 
it is a factor often referred to in the compliance literature 
very few studies have systematically investigated it. 
The major findings of the few studies reviewed 
suggest that despite the characteristics of the patient, 
the behaviour of the health care provider can largely 
determine whether or not individuals will be compliant 
with their prescribed medical advice. 
The most important conclusions drawn from the 
studies are summarised below: 
1. A predominant variable is that of communication. 
Although inconsistent, the findings from studies generally 
indicate that where the communication is actively twofold 
and not merely passively received by one party, higher 
compliance is more likely. 
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2. When significant others are taking responsibility 
for the administration of medical advice on behalf of 
someone else,i~e. a parent administering medication to a 
child, the degree of friendliness or antagonism expressed 
by the doctor is significantly related to the compliance 
by the significant other. 
3. The medication regimen is regarded as a major part 
of the doctor-patient interaction as it is traditionally 
initiated by the doctor and followed by the patient. 
Studies confirm previous findings that the more complex 
the regimen, and the less that is known about the function 
of the medication by the patient, the more medication errors 
are made. 
4. When doctors engage in more extensive follow-up, 
and caringly but firmly encourage and motivate individuals 
not complying with medical advice, compliance is enhanced. 
5. When the prescribing doctors give the impression 
that they believe in the efficacy and importance of the 
medication prescribed,compliance is increased. 
The major criticism made by the few researchers 
who have used this model, is that the relevant aspects of 
the doctor-patient interaction have not yet been adequately 
defined (Hulka, 1979). The paucity of literature using 
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this approach also means that more research must be under-
taken before more definite conclusions can be made. 
An attempt has been made to extend the doctor-
patient relationship model by incorporating it within the 
framework of the interactionist model of compliance, 
described by Dracup and Meleis (1982). 
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2.5.4 Interactional Model 
Disillusioned with the other approaches available 
at the time, Dracup and Meleis (1982) proposed a new model. 
Reflecting upon: 1) the extremely limited extent to which 
the variables categorised under the individualistic models 
could be modified, and 2) the degree to which responsibility 
for noncompliance was placed entirely upon the client by 
both types of models, Dracup and Meleis proposed the develop-
ment of an interactional approach to compliance. This 
approach utilises role theory and considers in more detail 
the subsequent influence of environmental and social inter-
actions upon medication compliance. 
When developing the interactional model, Dracup and 
Meleis (1982), based their theory upon three assumptions: 
1. Compliance was the outcome of a health transaction 
composed of roughly three stages. These stages included 
periods before, during and after any direct interaction 
between the doctor and patient. The third stage in particular 
represented the interval after the interaction when the 
patient either did or did not comply with the recommended 
advice. 
2. Three conditions proposed by Sackett (1976b) concern-
ing the necessity for (i) patient consent, (ii) accuracy of 
diagnosis and (iii) clinical efficacy of any proposed 
treatment; should be present before researching and/or 
experimenting with compliance/noncompliance. 
3. Compliance could not be understood by considering 
patient characteristics alone, but must also examine the 
effect of the patient's interactions with significant others 
and his environment, upon compliance. 
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As a basic concept of role theory, 'role' 
refers to "a patterned sequence of learned actions or 
deeds performed by a person in an interaction setting" 
(Sarbin, 1954, p.225). Within this setting roles elicit 
two kinds of expectations: 1) expectations anticipated 
by one participant of an interaction (A), from the 
participant of the reciprocal role (B), and 2) obligations 
which A anticipates to direct toward B. 
According to Lindesmith and Strauss (1968) role 
enactment involves four necessary elements: 1) self-concept, 
2) performance of appropriate behaviour in given situations, 
3) experience of complementary roles to help guide perform-
ance, and 4) periodic evaluation of the role by the individual 
and others in counter roles. 
While role enactment outwardly involves the 
performance of certain behaviours, if a person lacks the 
necessary role expectations, acquired through experience, 
he will be unable to enact the role. 
Based on these considerations, the interactional 
model isolates four main components which it considers in 
relation to levels of compliance/noncompliance. These 
include: 
1. The behaviours incorporated within the compliant/ 
noncompliant act as required by a new role. With respect 
to health care this may involve excluding previously 
familiar behaviours (e.g. smoking, eating certain foods) 
and/or learning new behaviours (e.g. taking regular 
medication, undertaking daily exercise). 
2. One's self-concept, focusing especially upon 
any changes incurred during the transition from a well 
role to a sick or at risk role. 
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3. The influence of counter roles played by significant 
others, e.g. health professionals and spouses. 
4. The evaluation periodically of roles as performed 
by oneself and others in counter roles. 
Therefore an individual compliant with health 
regimens would typically identify himself with a compliance 
role, using available cues and behaviours of the proposed 
role and cues received from others to perform the appropriate 
role. He would then also evaluate himself and others 
according to that role. 
Based upon these components the model proposes 
seven potential hypotheses: 
1) To the extent [that] a client demonstrates 
knowledge and competency in enacting a 
proposed role, a higher level of health 
regimen is expected. The relationship is 
mediated through the level of complexity 
and duration of the medical regimen ... 
2) Competency is maximised when there is 
evidence that the sick or at risk roles have 
been incorporated into the self-concept of 
the client ... 
3) Compliance is enhanced when relevant 
other roles are congruent and/or complemen-
tary with client roles ... 
4) Compliance is enhanced if the compliance 
role is reinforced by significant others 
and other reference groups ... 
5) The level and extent of a client's 
compliance with a.health care regimen depends 
on the degree to which behaviours of 
compliance are judged valuable by the client 
and are validated by significant others ... 
6) Nursing interventions directed toward 
increasing compliance depend on a careful 
assessment of omissions or commissions in 
each of the four proposed components of 
role enactment ..• 
(7) All four components of role enactment 
have to be present for compliance to 
occur. (Fig. 1) . 
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Dracup & Meleis, 1982, pp.34, 35) 









Note: From "Compliance" An Interactionist Approach" by 
K.A. Dracup and A.I. Meleis, 1982, Nursing Research, 
-p. 31. 
To date the study of lithium compliance amongst 
manic depressives, has been characteristic of the 
individualistic approach, focusing upon the discovery of 
variables to distinguish compliers from noncompliers. 
Jamison and Akiskal (1983) reviewed these variables and a 
summary of their findings follows: 
1. Demographic variables - few demographic variables 
have reliably predicted lithium compliance. Only three 
variables have shown a relationship: 
(a) patients with prior histories of mania tend to be 
less compliant than those with a prior history of 
hypomania; 
(b) increasing age and a greater number of effective 
episodes requiring treatment were associated with 
increasing compliance. This suggests that increased 
compliance may be secondary to decreasing denial 
as the illness continues to recur; and 
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(c) the number of months on lithium significantly 
differentiates the compliant from the noncompliant, 
with more people discontinuing lithium during long 
term treatment - a finding consistent with other 
compliance studies. 
2. Missing of highs - this factor significantly 
differentiated compliant from noncompliant patients. A 
further study reported that noncompliance was associated 
with elevated mood althoush the direction of causality was 
not specified. 
3. Side effects - findings suggest the occurrence 
of side effects may not be as important in lithium non-
compliance as is commonly thought. 
4. Decreased insight, when individuals feel well and 
see no need for further medication,has been found to be 
significantly related to lithium refusal. 
As isolated instances in a number of cases the 
majority of these findings need to be repeated to help 
ascertain their validity and accuracy. 
Jamison and Akiskal (1983) concluded by advising 
doctors treating manic depressives to become more aware of 
the effect an interaction of sociocultural, patient, illness 
and medication variables could have on lithium compliance. 
2.5.5 Conclusion 
Until the development of the interactional model 
of compliance in 1982, the three prevail~ng approaches 
' 
included: 1) the individualistic model, 2) the health 
belief model, and 3) the doctor-patient relationship. 
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The most common approach to the study of health 
care compliance has been the individualistic models. 
Assuming that compliant and noncompliant individuals can 
be differentiated by quantifiable and identifiable 
characteristics alone, the models generated much research 
comparing numerous variables with compliance. Results 
from studies using this approach have produced inconsistent 
findings. 
The HBM also generated much compliance research, 
postulating that an association existed between health 
behaviour and individuals' perceptions of themselves in 
relation to their disorders. Study findings using this 
model have also been inconsistent. 
In opposition to the strong emphasis these two 
approaches placed on the individual taking full responsibility 
for noncompliance, some researchers turned to investigate 
how the doctor-patient relationship might influence 
compliance. Theorising that the behaviour of the health 
care provider could greatly influence compliance, the model 
proposed that doctors should take a greater responsibility 
for a patient's noncompliance. Although still in need of 
revision and additional research, a review of the majority 
of research findings investigating the DPR support its 
hypothesis. 
With similar feelings towards the individualistic 
and HB models, Dracup & Meleis (1982) developed the inter-
actional model, encompassing and expanding upon the 
principles of the DPR theorists. Based upon role theory 
the interactional model considers the influence of 
environmental and social interactions upon compliance. 
However, as a relatively new model it is still in need 
of much study. 
To date, the study of lithium compliance amongst 
manic depressives has focused upon discovering variables 
which might distinguish compliers from noncompliers. A 
few findings show a relationship to lithium compliance, 
although the majority of these need to be repeated to 
determine their validity and accuracy. 
2.6 RATIONALE 
The literature reviewed points to a need for 
additional research into compliance using a model that 
investigates the effects of interactions upon compliance. 
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The interactional model subsequently serves as the theoretical 
basis for the study to follow which examines lithium 
compliance by manic depressive outpatients. 
Manic depressives and lithium compliance have been 
chosen for several reasons: 
1. Lithium has become a popular form of treatment for 
manic depression, having been universally acknowledged 
for its prophylactic effectiveness (J.M. Davis, 
1976; Petursson, 1979; Prien & Caffey, 1977; 
Quitkin, Rifkin & Klein, 1976; Schou & Thomsen, 
1975). 
2. Being an effective prophylactic treatment lithium 
is usually prescribed on an exceptionally long term 
or life-long basis. 
3. The consequences of lithium nonresponsiveness 
amongst manic depressives and inadequately or 
untreated manic depression, are typically 
associated with recurrences of symptoms and 
hospital readmissions. This may lead to 
occupational, financial, personal and emotional 
disruptions (Connelly, Davenport & Nurnberger, 
1982; Jamison & Akiskal, 1983). 
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4. The consequences of lithium noncompliance are as 
profound and destructive as lithium nonresponsiveness 
with the exception that noncompliance is reversible. 
5. Lithium noncompliance is common and is a particularly 
frustrating clinical problem. Up to 75% of all 
relapses among patients on lithium are attributable 
to negligence, i.e. noncompliance (Baastrup as noted 
by Van Putten, 1975). 
As reviewed earlier, a survey of the lithium 
literature indicates that noncompliance amongst individuals 
ranges from 20 - 52%, a finding consistent with non-
compliant levels reported in studies of other long term 
medications. 
The following study investigates lithium compliance/ 
noncompliance using the interactional model as a basis. 
It examines variables with a greater capacity for modifica-
tion than those proposed by the individualistic models. 
In addition it also allows for a greater sharing of 
responsibility for lithium noncompliance than either the 
individualistic or health belief models. 
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2.7 HYPOTHESES 
The hypotheses as they stand are very loose and 
nonspecific. Having now defined the study and sample to 
be worked with, it is appropriate to review the hypotheses, 
redefining and elaborating upon each as it relates tq the 
study. 
Of the seven hypotheses proposed by Dracup and 
Meleis (1982), and quoted earlier, six are tested in the 
study. The seventh hypothesis which refers to nursing 
interventions was not tested because of its inappropriate-
ness to the outpatient sample being studied. 
All variables extracted from the hypotheses were used 
as a basis for the creation of questionnaire items. 
Hypothesis 1: "To the extent [that] a client 
demonstrates knowledge and competency in enacting a proposed 
role, a higher level of health regimen compliance is 
expected. The relationship is mediated through the level 
of complexity and duration of the medical regimen 11 
(Dracup & Meleis, 1982, p.34). 
The proposed roles the authors are referring to in 
the above extract are the 'sick' and 'at risk' roles. The 
'sick' role is associated with the diagnosis of a disease 
or illness. Behaviours of compliance in this instance 
are comparable to an individual agreeing to follow behaviours 
prescribed in a medical regimen to help overcome an illness. 
In contrast the 'at risk' role is associated with the need 
to prevent the possible recurrence of a certain disease 
or disorder. Behaviours of compliance in this instance 
are comparable to an individual recognising his risk for 
developing or experiencing a recurrence of a certain 
disorder and complying with a medical regimen to decrease 
that risk (Dracup & Meleis, 1982; Kasl & Cobb, 1966). 
The main difference between the two roles involves the 
distinction between cure and prevention respectively. 
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The assumption is made that all individuals suffering 
from manic depression who are treated with, and respond to, 
lithium carbonate are representative of individuals in the 
at risk role. This assumption is supported by the use of 
lithium as a prophylactic medication for manic depression. 
Considering the application of the at risk role to 
this hypothesis, the variables contributing to its analysis 
endeavour to measure the subject's probable internalisation 
of compliance within the role's expectations. 
When extracting the variables to be analysed from 
the hypothesis, a problem arose with the variable of 
competency. Interpretation of 'competency' was difficult 
due to a lack of definition by Dracup and Meleis (1982). 
When it was subsequently defined to refer to a person's 
ability to enact a particular role, measurement by way of 
questionnaire seemed impracticable. As a variable it 
appears more suited to measurement by direct observation 
which was unrealistic for this study. For this reason 
competency has been omitted from the analysis of this 
hypothesis. The other variables extracted Were: 
1) level of personal acceptance of manic depression, 
2) individual awareness of one's need to regularly take 
lithium, 3) level of knowledge about one's personal medica-
tion regimen, 4) complexity of medication regimen, and 5) 
duration of lithium medication regimen. 
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It was hypothesised that the interaction of the first 
three variables would influence one's compliance to lithium, 
which would be further affected by the level of complexity 
and duration of the person's medication regimen. As 
reviewed earlier complexity and duration of medication 
regimens were two out of less than ten identifiable 
variables studied which have shown some consistent relation-
ship to compliance. 
Hypothesis 2: "Compliance is maximised when there 
is evidence that the sick or at risk roles have been 
incorporated into the self-concept of the client" (Dracup 
& Meleis, 1982, p.34). 
With the emphasis once again upon the at risk role 
the variables contributing to its analysis, as for hypothesis 
one, endeavour to measure the subject's probable internalisa-
tion of compliance within the role's expectations. The 
variables focus upon two main areas: 1) personal attitudes 
towards having manic depression, and 2) individual perceptions 
of susceptibility to manic depression. It is assumed that 
the interaction of both variables will provide some 
evidence of whether or not the at risk role has been 
incorporated into the self-concept. 
The variable which considers perceptions of sus-
ceptibility to manic depression in the analysis of this 
hypothesis, is the same variable used in hypothesis one to 
investigate individual awareness of one's need to regularly 
take lithium. It has been repeated in this analysis 
because it is thought to represent a major characteristic 
of the at risk role. The importance of what may otherwise 
be termed 1 insight', is supported by the findings of 
del Campo, Carr & Correa (1983) and Van Putten, Crumpton 
and Yale (1976). These researchers found that lack of 
insight was a strong discriminating variable between 
compliers and noncompliers with the latter lacking 
insight. 
Considering the focus upon the self-concept, it 
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was also thought appropriate to administer a self-concept 
scale and the Multidimensional Health Locus of Control 
(MHLC) scale. Although not directly related to the outcome 
of the hypothesis' results, the two instruments would 
provide additional information as to whether or not any 
significant differences in either perception of real self 
or locus of control amongst individuals of the two groups, 
existed. Further ~nalysis would investigate the relation-
ship of each measurement to reported noncompliance. 
Self-concept has been investigated very few times in 
relation to compliance and even then with inconsistent 
results. In 1976 Heinemann, Moore & Gurel investigated 
whether self-concept amongst a number of other variables 
might discriminate and therefore help predict those people 
likely to complete an alcoholism programme. Their findings 
-reported no association. In addition in 1973, Brown & 
Brewster compared concepts of real and ideal selves amongst 
compliers and noncompliers. 
tion between the two. 
They found a negative associa-
The locus of control construct has shown in past 
research a small association with medication compliance, 
with internally oriented individuals generally showing the 
more compliant behaviour (Anderson, Reed & Kirk, 1982; 
B.S. Wallston & Wallston, 1978a). A major attraction for 
using the M.HLC scale in particular concerned its 
specific relevance to health related behaviours. 
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Hypothesis 3: "Compliance is enhanced when relevant 
other roles are congruent and/or complementary with client 
roles" (Dracup & Meleis, 1982, p.35). 
The aim of hypothesis three is to determine whether 
or not subjects find themselves in roles which support 
a compliant stand within the at risk role. The roles chosen 
to study specifically have been broken down into four 
categories assumed to be evident in all of the subjects' 
lives. These include: 1) the doctor-patient relationship, 
2) one's work, 3) one's family, and 4) one's living situation. 
Each role will be studied independently to determine 
its influence upon each subject's level of compliance. A 
further analysis will examine the overall influence of all 
four roles together on compliance. 
Doctor-Patient Relationship. As reviewed earlier, 
the doctor-patient relationship is considered an important 
variable in determining whether or not patients will be 
compliant. Although some inconsistency in findings has 
occurred, generally communication, including confidence 
expressed by doctor and attitude of doctor towards patient, 
has been found to be an especially important determinant. 
The questions for analysis of the DPR in this 
hypothesis investigate the level of subject satisfaction 
with one's doctor. It is assumed that dissatisfaction 
with the level of communication, lack of approachability, 
lack of confidence and lack of support from one's doctor 
would indicate dissatisfaction with the relationship. 
Other questions provide more factual information such as 
length of time subjects have been patients with their 
present doctor. 
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In addition to the analysis of data for the hypothesis 
two other aspects of the DPR are examined. Dietrich and 
Marton (1982) suggested that the effect of a continuous 
relationship with a personal health care provider improved 
compliance with medication. Using one year as a 
discriminating variable, a chi2 analysis will compare the 
two groups. 
Past research has also shown a trend for mutual 
doctor-patient relationships, (where the doctor discusses 
decisions etc. with the patient), to promote compliance. 
This is in contrast to more authoritarian type relationships 
on the doctor's behalf which have been found to be associated 
with noncompliance (Korsch, Gozzi & Francis, 1968; Korsch 
& Negrete, 1972, as noted by Jay et al, 1984). 
Differentiating between authoritarian and mutual 
doctor-patient relationships a comparison between the two 
groups will be made using a chi2 analysis. 
Work. Despite many studies having investigated 
the effect of socioeconomic status upon compliance, no 
studies have investigated the effect of work upon 
compliance. 
The variable 'work' for the purposes of this study 
encompasses a broad range of activities including both paid 
and voluntary jobs. Subjects were free to decide for 
themselves if they had a 'job', given the one condition 
that it incurred some regular commitment on their behalf. 
Reported examples ranged from paid jobs such as industrial 
worker, postmaster, trainee manager and laboratory 
assistant, to voluntary jobs such as nurse aide, paper 
distributor and committee member. 
The questions relating to the variable of 'work' 
attempt to determine what effect a regular commitment to 
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a job might have on compliance. These questions in 
particular investigate: 1) whether or not one is 'working' 
and if so what it entails, 2) the importance of the job to 
those subjects working, and 3) the job's security if he or 
she needs to be rehospitalised. It is proposed that the 
more important a job is to a subject and the poorer the 
job's security in the case of rehospitalisation, the greater 
would be the likelihood of him or her being compliant. 
To analyse this proposition a group comparison will be made 
of the combined scores of the three questions. A correla-
tional analysis will also be made of these combined scores 
to determine its relationship with noncompliance. 
Finally the responses to each question related to 
'work' will be individually compared between the groups. 
Family. Past research indicates that the dynamics 
operating within the family may have some relationship 
with the level of compliance. Higher levels of medication 
compliance have been reported amongst patients with 
supportive families (Taylor, Sackett, Haynes & Johnson, 
1978), and noncompliance associated with more negative 
family relationships (Barsky, 1983). Spouse support has 
also shown strong associations with whether or not patients 
adhere to medication (Doherty, Schrott, Metcalf & Iasiello-
Vailas, 1983). 
The questions contributing to this variable 
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investigate the degree of support subjects feel they 
receive from family members. Questions also examine the 
extent to which subjects feel an episode of mania or 
depression would be disruptive to their respective families. 
It was proposed that the more supportive the family, the 
greater the likelihood of compliance. In addition, since 
roles involve expectations and obligations from both 
parties, it was proposed that the more disruptive a 
subject perceives an episode of manic depression would 
be for his or her family, the greater would be the obliga-
tion on the subject's behalf to be compliant. 
Living situation. Closely related to the aspect of 
family support are the conditions under which subjects live. 
For analysis of this variable, living situation has been 
scored in a similar way to the 'family' variable and attempts 
to ascertain satisfaction with present living situation. 
If someone lives by himself or is getting little support 
from those whom he lives with, it is proposed he will be more 
likely to be noncompliant than if he lives with others and 
receives support from them to be compliant. This is often 
referred to as supervision, a lack of which is recognised 
as contributing to patient noncompliance (Blackwell, 1976; 
Cummings, Becker, Kirscht & Levin, 1982; Evans & Spelman, 
1983; Seltzer, Roncari & Garfinkel, 1980). 
Porter (1969) found that among general practice 
patients on chronic medication, social isolation (living 
alone) was a major contributing variable to noncompliance. 
This will be studied using a chi2 analysis of group living 
situations. 
Hypothesis 4: "Compliance is enhanced if the 
compliance role is reinforced by significant others and 
other reference groups" (Dracup & Meleis, 1982, p.35). 
This hypothesis identifies two main variables to 
be studied: 1) the influence of significant others and 
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2) the influence of support groups; as they both contribute 
to the encouragement and reinforcement of subjects' compliance 
in the at risk role. 
Considering the strong influence of people such as 
one's family and doctor upon compliance as already reviewed, 
it is reasonable to assume that other people significant in 
subjects' lives will also be influential. This proposal has 
been put forward for investigation. 
Support groups have grown in popularity relatively 
recently. With no information previously reported about 
their relationship to compliance the opportunity now 
arises to study this interaction. 
The questions contributing to each variable 
respectively investigate: 1) the role significant others 
play in reinforcing the at risk role as perceived indirectly 
by each subject, and 2) how helpful support groups are to 
members and what relationship they have to compliance. 
Hypothesis 5: "The level and extent of a client's 
compliance with a health care regimen depends on the degree 
to which behaviours of compliance are judged valuable by the 
client and are validated by significant others'' (Dracup & 
Meleis, 1982, p.35). 
The two main variables derived from the above 
hypothesis for analysis represent: 1) perceived value of 
compliant behaviour, and 2) validation of medication 
compliance by significant others. 
Interpretation of this hypothesis was difficult 
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because the authors had not defined 'behaviours of compliance', 
For the purposes of analysis: favourable individual 
attitudes towards medication, favourable reports about its 
effectiveness in helping individuals cope with manic 
depression, and individual responses reaffirming the 
importance of taking medication as prescribed by their 
doctor, were categorised and analysed as behaviours of 
compliance. 
With respect to the second variable, it is considered 
important that the validation by others be measured indirectly 
according to the subject's perception. 
It is assumed that high cumulative scores obtained 
from questions contributing to each variable would be 
indicative of compliance while low scores would be indicative 
of noncompliance. 
Each variable and the combined effect of both 
variables will be compared between the groups. These 
three variables will then be individually analysed to 
determine their independent relationships to reported 
noncompliance. 
Hypothesis 6: "All four components of role enactment 
have to be present for compliance to occur" (Dracup & Meleis, 
1982, p.35). 
The four components which hypothesis six refers to 
are: 1) compliance role enactment, 2) incorporation of role 
into self concept, 3) counter roles, and 4) periodic 
evaluation of role. 
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These components are equivalent to those upon which 
the original hypotheses were formulated. This final 
hypothesis represents the bringing together of those 
hypotheses before it, and basically underlies the inter-
actional model's theory of compliance. 
Analysis will involve an examination of the results 
from the earlier hypotheses tested. This will be followed 
by an examination of a combination of variable scores 
between groups, and a correlational analysis of these 
combined scores with reported noncompliance. 
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CHAPTER 3 
MATERIALS AND METHODS 
3.1 SUBJECT SELECTION 
Forty-five individuals from a local support group 
for manic depressives and sixty-six individuals recently 
discharged from a psychiatric hospital, with diagnoses of 
manic depression were individually approached by means of a 
letter written by the author (Appendix 1). The letter 
outlined that a study, investigating the effects of manic 
depression on people's lives was being undertaken. In 
particular, personal attitudes of individuals with manic 
depression towards the disorder, attitudes of others towards 
them,and various aspects of medication were being studied. 
Individual replies to the author's enclosed telephone number 
were encouraged. Those people who did not voluntarily 
respond to the letter were later personally contacted by 
the author and asked if they were interested in participating. 
If they were not, persuasion was not applied. 
Once contact was made with potential subjects, 
questions referring to the object of the study were 
discussed. During the conversation reference was made to 
the layout of the questionnaire's three sections but no 
specific comments were made concerning the author's prime 
interest. 
Initial plans were to have two evenly divided 
















Unfortunately difficulty was experienced locating 30 non-
compliers. Because the level of compliance could not be 
ascertained until after administration of the questionnaire, 
time restrictions necessitated terminating interviews after 
21 noncompliers and 43 compliers had been identified. 





To have had at least one hospitalisation caused by 
manic depression. 
To have a current hospital diagnosis of manic 
depression. 
To be undergoing current treatment with lithium 
carbonate. 
The final sample of 64 subjects can be categorised 















( ) No.of Ss. 
under 20 20-29 30-39 40-49 50 years 
years years years years and over 
Ag~ 
Fig. 2. Sample in terms of age and sex 
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3.2 SELECTION AND DEVELOPMENT OF RESEARCH INSTRUMENTS 
All subjects completed three sections of a 
questionnaire composed of: 1) a measurement of self-concept, 
2) a questionnaire designed to measure attitudes and medica-
tion compliance, 3) the Multidimensional Health Locus of 
Control Scale. 
Before finalising the complete questionnaire format, 
it was piloted on four manic depressives presently being 
treated with lithium carbonate. This successfully identified 
questions in need of rewording and other small oversights. 
3.2.1 Measurement of Self-Concept (see Appendix 2) 
The semantic differential rating technique originally 
developed by Osgood, Suci & Tannenbaum (1957) was used to 
design an instrument to measure each subject's personal 
perception of their real self using the construct 'ME (AS I 
REALLY AM)'· Subjects rated themselves on this construct 
against 23 seven-point rating scales composed of bipolar 
adjectival opposites. Scale polarity was randomised to 
control for response set. 
The semantic differential technique (S.D.T.) has 
been a popular method of measurement for self-referent 
constructs. More than 80 studies, up to 1974, had used it 
to measure such constructs (Wylie, 1974, p.224). Findings 
from other researchers since 1974 also support its use as a 
measure of self-concept (Drummond & McIntire, 1977, 
Piotrowski, 1983). 
The self-referent construct 'ME' was used by 
Osgood et al (1957) in their first two factor analyses of 
scale correlations. These analyses yielded three main 
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orthogonal semantic response factors: evaluative (good-
bad), potency (weak-strong) and activity (slow-fast), which 
have now become synonymous with the S.D.T. Osgood et al 
interpreted these factors as basic dimensions of connotative 
meaning or semantic space (Wylie, 1974). These three factors 
have continued to reveal themselves in the analyses of diverse 
studies using varied concepts and subjects. 
Due to the prominence of the evaluative (E), potency 
(P), and activity (A) dimensions, scales associated with 
these three factors were chosen when constructing the present 
measurement of self-concept. 
The semantic differential is a technique used for 
developing individual research instruments and not a specific 
test as such. Consequently there are no standard scales 
or constructs which must be used. When designing the 
instrument for this study, note was made of many past findings 
from research using the S.D.T. The scales were selected from 
what has come to be known as the 'Thesaurus study' (Osgood 
et al, 1957, pp.47-66). They were chosen for their repres-
entation of the three major factors and also for their 
appropriateness to the construct being studied. 
Of the 23 scales chosen, 13 evaluative, 6 potency 
and 4 activity factorial scales were included. The unequal 
weighting of factorial scale numbers represented a selection 
of 50% of the scales documented under the three E.P. & A. 
factors. Within each factor the selection of scales 
represented those with the highest loadings on their respec-
tive factors. Five scales, (honest-dishonest; free-inhibited; 
unfriendly-friendly; brave-cowardly; selfish-unselfish) 
were not the actual ones tested in the original study but 
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were acknowledged by Osgood et al (1957) as being related 
to those in the analysis. 
Objectivity: The method of data collection is 
essentially objective and reproducible, with any subjectivity 
being restricted to analysis of the results. 
Reliability: Test-retest reliability coefficients 
from a variety of studies using the S.D.T. have been high. 
Osgood et al (1957, p.126-7) reported a coefficient of 
0.85, Jenkins, Russell & Suci (1958) reported a coefficient 
of 0.97, and more recently Piotrowski (1983) reported low 
but significant test-retest correlations on all scales 
tested. Unfortunately these scores were not reported. 
Several studies reported by Osgood et al (1957, 
pp.129-132} also reported a small error of measurement of 
less than one scale unit, indicative of high reliability. 
The statistical significance of such a small error of measure-
ment was recorded at the 0.05 level. 
Validity: Osgood et al (1957) consider there is 
little question about the general face validity of the 
S.D.T. finding that it clusters concepts in much the same 
way as people do. 
The three factors E.P. & A. have been validated 
(Heise, 1969) and cross cultural studies have consistently 
found the same semantic structure across different 
languages (Jakobovits, 1966, Kumata & Schramm, 1969). This 
work also substantiates the comparability of the S.D.T. 
across subjects. Note is made of the low level of compara-
bility across concepts. However, considering one of the 
functions of the S.D.T. is to differentiate individual 
meanings of constructs, this comment does not appear valid. 
Scoring of this instrument is outlined in Appendix 3. 
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3.2.2 Measurement of Attitudes and Medication Compliance 
(see Appendix 4) 
This questionnaire was constructed with the 
principal goal of collecting data for analysis of the 
proposed hypotheses. Each hypothesis was individually 
analysed and appropriate questions relating to each one 
were written generating over 150 questions. These were 
systematically reviewed until the minimum number thought 
necessary for analysis of each hypothesis, and additional 
compliance and personal information,remained. This resulted 
in 66 items with approximately 50% factual and 50% 
additudinal. 
Table 1 provides a breakdown of which questions 
provide information for which variables. These variables are 
subsequently associated with specific hypotheses and additional 
areas of interest. Hypotheis 6 is not included on this 
breakdown of the questionnaire as this hypothesis simply 
involved an analysis of the previous hypotheses. 
Some questions provided information for more than 
one hypothesis enabling some economising on questions. 
Question 57 for example provided information about the 
subject's attitude towards the use of medication, applicable 
to hypothesis 2, while also providing information applicable 
to hypothesis 5. 
Included amongst these 66 questions was a five 
question self-report lithium compliance questionnaire 
developed and used by K. Kucera-Bozarth (person~l communication 
20 April, 1984), (see Appendix 6). The original questions 
were modified slightly and are included in questions 18, 
59, 60, 61 and 62. 
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Table 1 Breakdown of attitudinal questionnaire into 
questions, variables and hypotheses 
Questions Variables 
Hypothesis 1 
12 & 13 
23 
Hypothesis 2 
12 & 13 
14,15 & 16 
17 
19-23 inclu-
sive, 57, 58 
& 62 
Hypothesis 3 













57,58 & 62 
Recognition of personal risk involved in 
being noncompliant. 
Personal acceptance of manic depression. 
Personal recognition of susceptibility to 
manic depression. 
Knowledge and complexity of personal 
medication regimen. 
Duration of medication regimen. 








Value of compliant behaviour to significant 
others as perceived by subject. 
Perceived value of medication and compliant 








64,65 & 66 
Sociodemographic and personal questions 
Compliance Measurement 
Patterps of noncompliance 
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The inclusion of a self-report measurement of 
compliance was considered adequate and appropriate for this 
study. Reflecting upon the methods used for measuring medica-
tion compliance reviewed earlier, all methods are recognised 
as having some inadequacies. With respect to lithium 
measurement, what is generally regarded as the most objective 
method, i.e. serum lithium testing, is still subject to a 
major limitation. If unusually large quantities of lithium 
are consumed prior to a scheduled serum lithium test an 
extremely noncompliant person will appear faithfully compliant, 
(Schwarcz, 1980). Considering the limitations of the various 
methods of measurement and the resources available, it was 
decided to restrict compliance measurements to self-report. 
Nevertheless a check was made of the reliability of the self-
report measures, against a number of blood tests. The results 
of serum lithium tests undertaken by 17 subjects within 2 weeks 
prior to the author's interview with them were compared with 
their reported levels of compliance for those 2 weeks. 
Nineteen per cent (N=4) of the noncompliers and 
30.2% (N=l3) of the compliers had had blood tests within two 
weeks prior to the interview (Table 2). 
The blood test levels for each of these noncompliers 
was less than their average lithium level (taken as the average 
of their last five blood serum lithium levels). In comparison 
only five of the thirteen compliers had lithium levels less 
than their average reading. A noticeable difference equivalent 
to 0.10 mrnole/1 differentiates the noncompliers last lithium 
levels with their average recorded lithium levels. In com-
parison a difference of only 0.01 mmole/1 differentiates 
the compliers' last lithium levels with their average 
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recorded lithium levels (Table 2). Although not statistically 
si~nificant the results do show some face validity when 







Figures relating to subjects having had blood 
tests within two weeks prior to interview 
Ave.of Last % of Self reported 
% of Last Ave. 
Lithium Noncompliance 
Lithium Lithium Level Level Group N 
Level Level Min :Max Ave Min Max 
19 4 0.46 0.56 0.28 0.64 27.9 11. 9 64.3 
30.2 13 0.57 0.58 0.46 o. 78 0.5 0.0 4.7 
The most direct questions of compliance were asked 
towards the end of Section Bas part of the questionnaire 
interview. Honesty in responding to questions was encouraged 
by promoting a relaxed interview, a nonjudgemental attitude 
towards subjects' replies, and developing rapport during the 
interview. For the scoring procedure see Appendix 5 . 
3.2.3 .Muldimensional Health Locus of Control (MHLC) Scale* 
The MHLC scale reflects the extent to which individual~ 
perceive their health to be dependent upon their own behaviour 
(internal health locus of control); chance, fate or luck 
(chance health locus of control); and powerful others (power-
ful others health locus of control). It consists of 18 state-
ments with six responses ranging from 'strongly disagree' to 
'strongly agree' yielding scores on three theoretically and 
empirically differentiated scales. Two equivalent forms of 
the scale are available. They were validated by O'Looney 
* pe~ Appendix 7. 
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& Barrett (1983) who reported a factor validity coefficient 
greater than 0.90 when correlated with one another. Form A 
was selected for use in the present study. 
The MHLC scale was chosen because of its reported 
superiority in understanding specific health-related 
behaviours. Past evidence indicates that the locus of control 
construct is relevant to the prediction of health behaviours 
including medication compliance (B.S. Wallston & Wallston, 
1978). Internally oriented individuals have generally shown 
the more positive behaviours but contradictory evidence has 
also been reported. 
The MHLC scale extended from the work of other locus of 
control researchers, such as Levenson (1973a&b, 1974) and 
Rotter (1966), also expanding upon the original health locus 
of control scale developed by B.S. Wallston, Wallston, 
Kaplan & Maides (1976). 
Reliability: Alpha reliabilities range from 0.673 
to 0.767 (K.A. Wallston, Wallston & De Vellis, 1978). 
Validity: Health status was correlated with MHLC 
scores, correlating positively and significantly with 
internal health locus of control (r =.403, p< .001), 
negatively with chance health locus of control (r =-~.275, 
p< ,.0l), and not at all with powerful others health locus 
of control (r = .055). It is acknowledged however that as a 
relatively modern instrument more research is required to 
more accurately determine the reliability and validity of 
the instrument (K.A. Wallston et al 1978). For the scoring 
procedure see Appendix 8. 
3.3 PROCEDURE 
The Chairman of the Canterbury Hospital Board's 
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Ethical Committee gave the committee's approval for the 
study to proceed after a detailed proposal was submitted to 
the committee in 1983. Changes made in 1984 were also 
approved by the committee. 
Data were collected during one interview with each 
subject which lasted on average two to three hours. 
Interviews extended over a three month period from August 
to October 1984 inclusive. Each interview was conducted by 
the author. 
Except for administration of the actual questionnaire 
each interview was largely informal, being conducted at each 
individual's home or flat. 
Before administration of the questionnaire, the 
author outlined the various aspects of the study as detailed 
on the front page of the questionnaire. It was explained 
to each subject that the information collected was required 
for personal university research and would be completely 
confidential. Contact with individual doctors would be 
necessary in order to confirm some of the information 
gathered, but no information would be passed on to their 
doctor. 
At this stage consent forms were signed by the 
subject agreeing to participate in the study. This also 
gave permission for the author to seek the necessary informa-
tion from their doctor. 
Following this the subject and author worked through 
the instructions and the first scale of Section A together. 
This helped make sure the subject understood what was 
required of him in responding to the scales. The subject 
then worked through the rest of Section A by himself. This 
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technique was used in preference to the subject and author 
working through it together as the task was thought to be 
an especially personal one. It was thought it would yield 
more honest responses and be less embarrassing to each 
subject if he was left to do it pimself. 
A structured questionnaire interview followed with 
both the subject and author working through the two remaining 
sections, Band C, together. The author wrote the subject's 
responses down on the subject's original questionnaire which 
he had just completed S"ection A on. Meanwhile the subject 
followed the questions being asked from a spare copy of the 
questionnaire. A break of 10-15 minutes was taken after 
question 36 in Section B. 
This interview technique was considered the most 
appropriate for the final two sections for a vareity of reasons. 
It provided a relaxed setting with neither individual feeling 
tense as sometimes happens when subjects are left to fill in 
a questionnaire, knowing someone is waiting for them to 
finish. It ensured that each ~ubject·was responding to a 
similar presentation of questions. It enabled the author to 
probe for more information where necessary and rephrase any 
questions not understood. It ensured no questions were missed 
out and total completion of all questionnaires. It was also 
found to save time. 
If tension was sensed by the author during any stage 
of the visit an effort was made to ease the situation. 
After completion of the subject interviews, subjects 
were assigned to one of two groups according to their level 
of self reported compliance. Gordis (1979) outlines a variety 
of methods used by researchers to categorise subjects into 
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compliant or noncompliant groups. The more commonly used 
method is to select an arbitrary level of noncompliance above 
which people are categorised as noncompliant and below which 
people are compliant. With no standard cutoff point regularly 
used in the literature on medication compliance an arbitrary 
level of 10% was chosen for this study. Group 1 (N = 21) 
consisted of subjects who reported 10% or greater non-
compliance over the previous two weeks, while Group 2 (N = 43) 
consisted of subjects with less than 10% reported non-
compliance. A cutoff point of 10% was chosen since in 
practical terms this represented at least the equivalent of 
l½ days total lithium noncompliance over the previous two 
weeks. This also allowed for 14 subjects who reported missing 
the odd one or two lithium accidentally to be still categorised 
as compliant. Considering the average level of reported 
noncompliance amongst the noncompliant group was 51.4% as 
against 1.2% amongst the compliers,there is a very large 
difference in the level of lithium noncompliance each group 
represents. 
The distribution of self-reported rates of noncompliance 
amongst the subjects is represented in Table 3. 
Following the termination of subject interviews, 
personal interviews with 22 doctors were arranaed. These 
were conducted by the author during November. During these 
interviews confirmation was made of each subject's last 
admission and discharge dates to hospital, medication pre-
scriptions, date of last blood serum lithium test and most 
recent hospital diagnosis. Note was also made of each 
subject's last five blood serum lithium levels. Information 
collected during these interviews was cross checked with 
the subjects' individual responses and note of any 
corrections was made where necessary. 
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Table 3 Distribution of Rates of Noncompliance over Two 






























































4.1 ANALYSIS OF DATA 
The variables which form the major part of the 
analysis for each hypothesis are composed of responses to 
appropriate questions in the questionnaire. Although one 
or two variables rely on scores from only one question, the 
majority of variables represent the cumulative score of a 
number of questions. Scoring was designed so that the 
higher the positive score, the greater was the likelihood 
of medication compliance. Similarly the lower the score 
the greater was the likelihood of noncompliance. 
With the exception of some 'descriptive' questions 
which used discrete data, all other questions used continuous 
data, which allowed for the testing of mean scores between 
groups and correlational testing with reported noncompliance. 
All comparisons between groups were analysed using 
the two-tailed t-test for means of independent samples. 
Data analysed with the t-test were required to be continuous, 
normally distributed within the two groups, with roughly 
equal standard deviations. When data were affected by 
either small groups or uneven distributions, a Mann Whitney 
U test was used also and both results are reported. In some 
cases at-test was obviously inapplicable and a Mann Whitney 
U test has been applied by itself. 
When the Mann Whitney U test was used, the size of 
the sample enabled the U statistic to be transformed into 
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a normally distributed statistic, z, which is corrected for 
ties. This is presented with its two-tailed probability 
confidence level (Hull & Nie, 198l, p.232). 
In the majority of compliance studies to date 
emphasis has been placed upon comparing arbitrarily defined 
compliant and noncompliant groups. This isolated method 
of analysis is questioned because of the unstandardised 
technique used to distinguish the groups. Consequently 
all data which would normally be analysed using only 
t-tests and Mann Whitney U tests have also been correlated 
with reported noncompliance to determine the nature of 
their relationship. 
Discrete data were analysed using the chi
2 
test to 
determine whether or not significant differences existed 
between the two groups on a variable. Unfortunately the 
nature of this data only allowed for group comparisons to 
be made. 
All statistical analyses used the SPSS package (Nie, 
Hull, Jenkins, Steinbrenner & Bent, 1975). 
4.2 HYPOTHESIS 1 
The first analysis was of the first three variables, 
1) level of personal acceptance of manic depression, 2) 
individual awareness of one's need to regularly take lithium, 
and 3) level of knowledge about one's personal medication 
regimen (Table 25). At-test and Mann Whitney U test were 
used. Results from both tests just failed to show a 
statistically significant difference between the groups 
(t = 1.95, p = .06; z = 1.89, p = .06). 
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The first analysis was repeated with additional 
scores from the fourth and fifth variables: complexity 
and duration of medication regimens, respectively (Table 25). 
These results showed no significant difference between the 
groups (t = 0.79, p = .43; z = 0.70, p = .48). 
The five independent variables and two combinations 
which contributed to the above analyses were individually 
analysed using Pearson's correlation to determine their 
relationship with reported noncompliance (Table 4). 
Table 4 Pearson's Correlation Coefficients of Hypothesis 
Variables with Noncompliance 




Correlation 64 -.11 -.31 -.20 -.27 .13 .03 -.15 
Probability 64 .20 p<.01 .06 .01 .16 
Key: 
A Personal acceptance of manic depression 
B Awareness of personal need to take lithium 
C Knowledge about personal medication regimen 
D Combination of variables A, B & C 
E Complexity of personal medication regimen 
F Duration of personal medication regimen 
.40 
G Complete role enactment - combination of variables 
A, B, C, E & F. 
.13 
Only one of the first three variables tested, aware-
ness of personal need to take lithium regularly, had a 
statistically significant negative correlation with level 
of reported noncompliance. This finding supports the 
hypothesis, although results from the other two variables: 
personal acceptance of manic depression, and knowledge about 
personal medical regimen which reported no specific 
association do not support the hypothesis. Nevertheless, 
when these three variables in combination were correlated 
with reported noncompliance a statistically significant 
negative relationship was found. This finding does 
support the hypothesis. 
Neither the complexity nor the duration of one's 
medication regimen, nor the combined effect of all the 
variables, showed statistically significant relationships 
with noncompliance. These final results do not support 
the hypothesis. 
4.3 HYPOTHESIS 2 
The t-test and Mann Whitney U test analysed for 
differences between groups in personal attitudes towards 
having manic depression (Table 25) . Results were 
statistically significant in both cases (t = 2.70, p<.01; 
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z = 2.16, p = .03). A second analysis used the t-test upon 
individual perceptions of susceptibility to manic depression 
(Table 25). Results were not statistically significant 
(t = 1.85, p = .07). 
A Mann Whitney U test analysed the combined effect 
of both variables: 1) personal attitudes towards having 
manic depression, and 2) individual perceptions of 
susceptibility to manic depression. Results showed a 
statistically significant difference between groups 
(z = 2.19, p = .03). 
Individual correlational analyses of both variables 
and their combined effect found statistically significant 
negative relationships between each variable and reported 
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level of noncompliance (Table 5). 
Table 5 Pearson's Correlation Coefficients of Hypothesis 2 
Variables with Noncompliance 












A Personal attitudes towards having manic depression 
B Individual perceptions of susceptibility to manic 
depression 
C Combined effect of A and B 
Based on the assumption that positive attitudes to 
having manic depression and realistic individual perceptions 
of susceptibility to manic depression are indicative of 
incorporation of the at risk role into one's self-concept, 
the results of both the between group and_correlational 
analyses support hypothesis 2. 
With respect to the results of the measurement of 
self-concept, an analysis was performed on the scores 
obtained by each group on the predetermined Evaluative, 
Potency and Activity factors. The t-test and .Mann Whitney 
U tests were used (Table 25). No significant results were 
found. 
(E t = 0.68, p = 50; z = 0.52, p = .60 
P t = 1.64, p = 10; z = 1.48, p = .13 
A t = 1.56, p = .12; z = 1.50, p = .13) 
The scores representative of each factor were also 
individually correlated with reported noncompliance 
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(Table 6). While the evaluative factor was not significant 
both the potency and activity factors showed statistically 




Pearson's Correlation Coefficients of Factors 
Underlying the Measurement of Self-Concept with 
Noncompliance 












A variety of factor analyses were performed on the 
scales to determine whether the Evaluative, Potency and 
Activity factors were dominant within the self-concept 
scale used. Although the scales used were initially chosen 
because of their high factorial loadings, the results failed 
to replicate past factorial analyses. 
When analysing the results of the MHLC scale, both 
the t-test and Mann Whitney U tests were used. 
The independent scores representative of the 
internal, powerful other and chance health locus of control 
scores were ascertained for each subject. The average 
group score of each locus of control was compared between 
the two groups (Table 25). The results were not 
statistically significant. 
(IHLC t = 0.41, p = .68; z = 0.32, p = .75 
POHLC t = 1.73, p = .08; z = 1.61, p = .10 




analysis performed between the two groups to 
determine if a greater percentage of either group had a more 
dominant locus of control (Table 7) was also not significant 
( X 2 Cd f = 3 , n = 6 4) = 1. 3 4 , p = • 7 2) • 







Health Locus of Control 


























0 Individuals without one dominant health locus of control 
l Internal Health Locus of Control 
2 Powerful Other Health Locus of Control 
3 Chance Health Locus of Control 
The scores representative of each health locus of 
control were also independently correlated with reported 
noncompliance (Table 8). The IHLC showed a statistically 
significant positive relationship with reported noncompliance 
although neither the POHLC nor the CHLC showed statistically 
significant results. 
Table 8 Pearson's Correlation Coefficients of Health 
Loci of Control Scores with Noncompliance 
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The analysis of data for hypothesis three was divided 
into five stages: 
1. Doctor-patient relationship 
2. Work 
3. Family 
4. Living situation 
5. Interaction of the four roles upon noncompliance. 
1. Doctor-patient relationship 
A Mann Whitney U test analysed subject satisfaction 
with the doctor-patient relationship to test for group 
differences (Table 25). Results were not significant 
(z = 1.41, p = .16). 
A correlational analysis of the doctor-patient 
relationship with reported noncompliance (Table 24) was 
not significant tr= -.18, p = .OB) Neither of these 
findings support the hypothesis. 
h · 2 1 ' d th l' t d Ac 1 ana ysis compare e comp ian an non-
compliant groups to determine if any difference existed 
with respect to length of time subjects had been patients 
with their present doctors (Table 9). Using one year as 
the discriminating variable results were not significant 
(x
2 
(df = 1, N = 64) = 0.12, p = .73). 







1 Less than 1 year 
2 Over 1 year 




















A second chi2 analysis tested whether or not type of 
relationship with doctor, i.e. authoritarian vs mutual, 
differentiated compliers and noncompliers (Table 10). No 
significant results were found <x 2 (df = 1, N = 64) = 
1. 71, p = .19) • 


















1 Authoritarian relationship on behalf .of doctor 












The ass~mption was made that a person with poor job 
security, who thought highly of his job would have more 
incentive to comply with his medication than someone who: 
a) wasn't working, orb) had a job with good security that 
wasn't especially important to him. Based on this 
assumption group scores were compared using at-test 
(Table 25). Results were not significant (t = 0.38, p = .70). 
A correlational analysis of work and reported non-
compliance (Table 24) did not show any statistically 
significant results (r = .02, p = .43). Neither of these 
findings support the hypothesis. 
A chi2 analysis investigated whether or not any 
differences existed between groups with respect to work' 
engaged in (Table 11). No significant differences were 
found (x
2 
(df = 2, N = 64) = 0.69, p = .70). 











0 Not working 
1 Voluntary work 





















A second analysis using chi2 examined whether or not 
work was more important to compliers than noncompliers 
amongst subjects working (Table 12). No significant 
differences were found (x 2 (df = 3, N = 29) = 0.22, p = .97). 













1 Slightly important 
2 Moderately important 
3 Very important 
























A third analysis used chi2 to examine between groups 
job security amongst working subjects if they were 
rehospitalised (Table 13). The results were not significant 
2 
(x (df = 1, N = 29) = 0.125, p = .72). 
Table 13 Job Security Amongst Workers 
Job Security Row 
Groups 1 2 Total % 
Noncompliant 6 2 8 
27.6 
Compliant 17 4 21 
72.4 
Column 23 6 29 
Total% 79.3 20.7 100.0 
Key: 1 Job would be kept open 2 Job would be lost 
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3. Family 
The analysis used at-test to examine whether or not 
any significant differences existed between groups with 
respect to support from and obligations towards family 
(Table 25). No significant results were found (t = 0.66, 
p = .51). 
A correlational analysis of family and reported non-
compliance (Table 24) was not significant (r = -.05, p = .36). 
Neither of these findings support the hypothesis. 
4. Living Situation 
At-test investigated level of satisfaction with 
living situation between groups (Table 25). Results showed 
no statistically significant differences (t = 1.68, p = .09). 
A correlational analysis of subjects' satisfaction 
with living situation and reported noncompliance (Table 24) 
found a statistically significant negative relationship 
(r = -.34, p<.01). Although the group comparison does not 
support the hypothesis, the correlational analysis does. 
Using a chi 2 analysis to compare type of living 
situation between groups (Table 14), no significant 
differences were found (x 2 (df = 2, N = 64) = 5.45, p = .07). 





1 Live alone 
Living Situation 






















2 Live with family 3 Live with others, not family 
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5. Interaction of the four roles upon noncompliance 
A Mann Whitney U test investigated the combined 
effect of all four variables: doctor-patient relationship, 
work, family and living situation upon compliance (Table 25). 
Results were not statistically significant (z = 1.86, 
p = .06). 
Correlations were also performed on each of the five 
variables to determine their individual relationship and 
combined relationship with noncompliance (Table 15). 
Table 15 Pearson's Correlation Coefficients of Hypothesis 
Variables with Noncompliance 
Variables N A B C D 
3 
E 
Pearson's Correlation 64 -.18 .02 -.05 -.34 -.24 
Probability 64 
Key: 
A Doctor-patient relationship 
B Work 
C Family 
D Living Situation 
. 07 
E Combined Effect of all variables 
.43 .36 p<.01 
Two variables showed a statistically significant 
negative relationship with noncompliance. These were: 
l) satisfaction with living situation, and 2) the combined 
effect of all variables. Each of these variables had 
confidence levels less than .05. 
The statistically significant negative relationship 
that the combined effect of all variables has upon non-
compliance supports the hypothesis. 
.03 
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4.5 HYPOTHESIS 4 
The Mann Whitney U test was used to compare the 
influence significant others had in reinforcing the at risk 
role, between groups. The results were not significant 
( z = 1 . 5 2 , p = . 13 ) . (Tab 1 e 2 5 , p . 8 7 ) 
A correlational analysis of the influence of 
significant others and reported noncompliance (Table 24) 
just failed to reach statistical significance (r = -.20, 
p = .06). These findings do not support the hypothesis. 
h · 2 1 ' d h b f Ac i ana ysis was use to compare t e num er o 
subjects who belonged to a support group (Table 16). 
Table 16 Support Group Membership Amongst Subjects 
Group Membership 
Groups 1 2 
Noncompliant 19 2 
Compliant 20 23 
Column 39 25 
Total% 60.9 39.1 
Key: 
1 Subjects who don't belong to a support group 










Results were statistically significant (x 2 (df = 1, N = 64) 
= 9.68, p<.001). 
A correlational analysis of perceived helpfulness of 
support groups with noncompliance used information supplied 
by the 25 subjects who belonged to a group (Table 24). 
Results showed a statistically significant negative relation-
ship (r = -.57, p<.001). 
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Additional analysis showed that the two noncompliant 
subjects who belonged to a support group, did not find it 
helpful. In comparison, only one of the 25 compliant 
subjects who belonged to a group found it not helpful. All 
the other subjects considered it either slightly, moderately 
or extremely helpful, evenly divided in each category. 
Although the majority of subjects belonging to a 
support group belonged to the local Manic Depressive 
Society's support group (76%), some subjects belonged to 
other groups. These included Alcoholics Anonymous (8% N=2), 
church groups (8%}, a hospital psychotherapy group (4%) and 
a community support group for individuals with psychiatric 
and psychological problems (4%}. Individuals found these 
other groups helpful to them in coping with their manic 
depression. 
The Mann Whitney U test examined the interaction of 
significant others and participation in a support group. 
It proposed that reinforcement from significant others and 
reinforcement from a support group would encourage high 
compliance (Table 25). The results were not statistically 
significant (z = 1.826, p = .07). 
A correlational analysis of the combined effect of 
reinforcement from significant others and participation in 
a support group with reported noncompliance (Table 17) found 
a statistically significant negative relationship (r = -.21, 
p = .04). While the group comparison does not support the 
hypothesis the correlational analysis does support it. 
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Table 17 Pearson's Correlation Coefficients of 
H:tpothesis 4 Variables with NoncomEliance 
Variables A B C 
N 64 25 64 
Pearson's Correlation -.20 
Probability .06 
A Influence of significant others 
B Helpfulness of support group 
-.57 -.21 
p<.001 .04 
C Support group participation and influence of significant 
others 
Two variables showed statistically significant 
negative correlations with noncompliance. These were: 
1) helpfulness of support group (as ascertained by the 
25 subjects belonging to a group) and, 2) the combined 
effect of participation/nonparticipation in a group with 
the additional influence of significant others. Although 
these results support the hypothesis care has to be taken 
interpreting them. 
4.6 HYPOTHESIS 5 
At-test and Mann Whitney U test were used to test 
for differences between groups according to the perceived 
value of compliance behaviours (Table 25). Findings were 
significant in both tests (t = 5.42, p<.001) , (z = 4.36, 
p<.001). These findings support the hypothesis. A second 
analysis used the t-test and Mann Whitney U test to test 
for differences in the validation of medication compliance 
by significant others (Table 25). Findings were not 
statistically significant (t = 1.85, p = .07) (z = 1.743, 
p = .08). 
A further analysis using the t-test and Mann 
79 
Whitney U test investigated the combined effect of both 
variables (Table 25). The results indicated a statistically 
significant difference between the two groups in the scores 
obtained (t = 3.48, p<.001) (z = 3.27, p<.001). 
Pearson's correlation coefficients were also used to 
determine the individual relationship of each variable to 
reported noncompliance (Table 18). All variables showed 
statistically significant negative relationships to non-
compliance. These results support the hypothesis. 
Table 18 Pearson's Correlation Coefficients of 
Hypothesis 5 Variables with Noncompliance 
Variables N A B C 
Pearson's Correlation 64 -.61 -.32 -.50 
Probability 64 p<.001 p<.01 p<.001 
Key: 
A Perceived value of compliant behaviour 
B Validation of medication compliance by significant others 
C Combined effect of A and B. 
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4.7 HYPOTHESIS 6 
The analysis of hypothesis six involved the testing 
of scores accumulated from the previous analysis of each 
hypothesis (Table 24). The accumulated scores represented 
continuous data which enabled a comparison of mean scores 
between the groups. The analysis considered the combined 
effect of the following variables upon compliance: 
1) knowledge in enacting the at risk role, 2) complexity 
and duration of medical regimen, 3) incorporation of 'at 
risk' role into the self-concept, 4) presence of congruent 
role expectations as demanded by other roles, 5) influence 
of significant others and participation in a support group, 
6) perceived value of compliant behaviour and 7) validation 
of medication compliance by significant others. 
At-test compared the mean cumulative scores of each 
group (Table 25). Results showed a statistically significant 
difference between groups (t = 3.25, p = .002). 
The combined effect of all the variables was 
correlated with reported noncompliance to ascertain the 
relationship between the two variables. Results were 
statistically significant (r = -.44, N = 64, p<.001). 
SOCIODEMOGRAPHIC VARIABLES 
An additional analysis was also made of general socio-
demographic variables included in the questionnaire. These 
variables were: marital status, sex, age, family history 
of manic depression, and length of time the manic depressive 
diagnosis had been known by the subject. 
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Table 19 Group Com2arisons of Sociodemographic 
Variables (N = 6 4) 
Variable 
2 
df X p. 
Marital Status 8.15 2 0.02 
Sex o.oo 1 1.00 
Age 12.89 4 0.01 
Education 5.23 5 0.38 
Family History 0.35 1 0.55 
Time 2.76 3 0.43 
A chi2 analysis found that both marital status 
(Table 20) and age (Table 21) showed statistically signifi-
cant differences between groups (Table 19). 
Table 20 Marital Status of Subjects (N = 6 4) 
Status Row 
Groups Single Married Div, Sep, Total % 
Widowed 
Noncompliant 14 3 4 21 
32.8 
Compliant 13 18 12 43 
67.2 
Column 27 21 16 64 
Total% 42.2 32.8 25.0 100.0 
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Table 21 Age of Subjects (N = 64) 
Age Row 
Groups Under 20-29 30-39 40-49 50-Yrs Total 
20 yrs. yrs yrs yrs & over 
Noncompliant 1 11 5 2 2 21 
32.8 
Compliant 1 6 11 12 13 43 
67.2 
Column 2 17 16 14 15 64 
Total% 3.1 26.6 25.0 21. 9 23.4 100.0 
COMPLIANCE VARIABLES 
An analysis was made of the other four modified 
questions from Kucera-Bozarth's self-report compliance 
questionnaire (Appendix 6). These questions investigated: 
1) the likelihood of being noncompliant and reasons for it, 
2) time of day medication had been taken, 3) number of 
lithium taken daily, and 4) importance to each subject of 
taking medication as directed by his or her doctor. 
U ' h'
2 1 ' t th lt sing a c i ana ysis o compare groups e resu s 
showed that all these questions as presented in their 
modified form showed statistically significant differences 
between groups. The results were in the expected direction 
for each group. The probability level for each question 
was less than .001. 
Other questions analysed under the heading of 
compliance-oriented variables were: 1) how long ago each 
subject had had his or her last blood test considering the 
necessity for patients on lithium to have blood tests 
% 
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approximately every three months, 2) whether or not subjects 
had been noncompliant before, and if so, for how long, 
3) amongst subjects who had been noncompliant before, how 
long ago had this happened, 4) were subjects aware of 
any specific consequences from having done this. Each 
aspect of compliance is analysed accordingly. 
Using chi2 for the analysis and three months as a 
discriminative variable, no significant differences were 
found between groups according to last time subjects had 
2 their serum lithium levels tested (x (df = 1, N = 64) = 
0.076, p = .78). 
Questions asking whether or not subjects had been 
noncompliant before, and if so, for how long were open-
ended. During coding four categories were created: 
1) once for less than a week, 2) once for over a week, 
3) more than once, for longer than a week each time, and 
4} not applicable. Analysing these categories between the 
groups (Table 22) using a chi2 analysis, a statistically 
2 significant difference was found (x (df = 3, N = 64) = 
16.5, p<0.01). 
Table 22 Periods of :erevious noncom:12liance 
Previous noncompliance 
1 2 3 4 
Noncompliant 2 1 14 4 
Compliant 4 3 8 28 
Column 6 4 22 32 
Total % 9.4 6.3 34.4 50.0 
Key: 
1 Once, for less than 1 week 
2 Once, for longer than 1 week 












Information from the 32 subjects of both groups who 
had been noncompliant before was tested to determine how 
long ago this happened. The three categories which 
resulted from the responses given to the open-ended questions 
were: 1) over one year ago, 2) within the last year, and 
3) prior to and during this year. A chi2 analysis tested 
for differences between groups amongst these categories 
but results were not significant (x 2 (df = 2, N = 32) = 
5.6, p<.10). 
Finally, an analysis between groups (Table 23) 
amongst the 32 subjects who had been noncompliant before 
showed a statistically significant difference in awareness 
of consequences from having done this (x 2 (df = 1, N = 32) = 
7.07, p<.05). 
Table 23 Consequences of east noncompliance 
1 2 
Noncompliant 8 9 
Compliant 2 13 
Column 10 22 
Total% 31. 2 68.8 
1 No awareness of consequences 










Table 24 Summary of Correlations of Variables with 
Noncompliance (N = 64) p< 
Variable Pearson's Probab-Correlation ility 
Hl - Acceptance -.11 .20 
Hl - Awareness -.31 p .01 
Hl - Knowledge -.20 .06 
Hl - Complexity .13 .16 
Hl - Duration .03 .40 
Hl - Role Enactment -.15 .13 
H2 - Attitudes -.44 p .001 
H2 - Susceptibility -.31 p .01 
H2 - Attitudes and Susceptibility -.47 p .001 
H3 - Doctor-Patient Relationship .02 .43 
H3 - Family -.05 .36 
I 
H3 - Living Situation -.34 .01 
H3 - Combined Effect of all 
Variables -.24 .03 
H4 - Significant Others -.20 .06 
* H4 - Support Group -.57 p .001 
H4 - Participation in Support 
Group and Significant 
Others -.21 .04 
H5 - Perceived Value -.61 p .001 
HS - Validation -.32 p .01 
HS - Perceived Value and 
Validation -.50 p .001 
H6 - All Hypotheses combined -.44 p .001 
H2 - IHLC .27 .02 
H2 - POHLC -.17 .08 
H2 - CHLC -.18 .07 
H2 - Evaluative Factor .03 .41 
H2 - Potency Factor .20 .05 
H2 - Activity Factor .24 .03 
* N = 25 
Table 25 Summary of Group Comparisons with Hypotheses 
Variable Group N Min Max Median Mean S.D. T-test Mann-Whitney 
Score Score T-score p. U-test 
z score p. 
Hl - Enactment of 1 21 1 15 6.2 6.9 3.6 1.95 .06 1.89 .06 at risk role 2 43 3 14 8.4 8.6 3.1 
Hl - Enactment of 1 21 -8 14 5.2 4.4 5.0 0.79 .43 0.70 .48 at risk role and 2 43 -2 14 5.9 5.3 3.6 
complex & duration 
H2 - Attitudes 1 21 -1 20 10.8 9.4 7.3 2. 7 0 p<.01 2 43 2 24 14.8 13.7 5.2 2.16 .03 
H2 - Susceptibility 1 21 0 6 3.2 3.1 1.8 1.85 to M.D. 2 43 0 6 4.1 3.9 1.6 .07 1.83 .07 
H2 - Attitudes and 1 21 -1 26 14.8 12.5 8.4 N/A N/A Susceptibility 2 43 7 30 17.3 17.7 5.7 2.19 .03 
H2 - Internal Health 1 21 14 36 25.0 26.1 6.4 .41 .68 Locus of Control 2 43 13 36 25.3 25.5 5.0 0.32 • 7 5 
H2 - Powerful Others 1 21 10 32 19.3 20.1 6.0 1.73 Health Locus of 2 43 10 35 22.3 23.1 6.9 .08 1.61 .10 
Control 
H2 - Chance Health 1 21 7 27 16.7 17.7 6.0 0.11 .90 Locus of Control 2 43 6 32 18.7 17.9 6.6 0.04 .96 
H2 - Real Self 1 21 40 85 70.3 68.8 10.0 0.68 .50 0.52 Evaluative Factor 2 43 43 86 71.3 70.4 8.6 .60 oo °' 
Table 25 (Continued) 
H2 - Real Self 1 21 15 42 26.0 25.9 6.2 
Potency Factor 2 43 15 34 23.4 23.7 4.4 1.64 0.10 1.48 0.13 
H2 - Real Self 1 21 10 28 20.3 19.5 4.4 
Activity Factor 2 43 8 25 18.0 17.6 4.5 1.56 0.12 1.50 0.13 
H3 - Doc~or Patient 1 21 -7 29 25.9. 20.1 11.7 
Relationship 2 43 3 29 26.8 24.9 6.1 N/A N/A 1.41 .16 
H3 - Work 1 21 -1 5 0.1 0.3 1.2 
2 43 -4 5 0.1 0.2 1.2 0.38 . 7 0 0.20 .83 
H3 - Family 1 21 -3 9 5.1 4.1 4.6 
2 43 -3 33 5.4 5.1 6.0 0.66 .51 0.26 .80 
H3 - Living 1 21 1 11 5.1 5.2 2.9 
Situation 2 43 0 11 6.4 6.5 3.0 1.68 .09 1.64 .10 
H3 - Combined Effect 1 21 4 47 29.0 29.7 13.2 
of 4 Variables 2 43 8 66 38.2 36.6 10.0 2.33 .02 1.86 .06 
H4 - Influence of 1 21 -14 46 21.0 19.6 14.3 
Significant Others 2 43 -9 46 25.0 26.8 17. 6 1.32 .19 1.52 .13 
H4 - Combined Effect of 1 21 -14 46 20.8 19.8 14.3 
Participation in a 2 43 -9 51 26.0 27.0 17.6 1.49 .14 1. 82 .07 
Support Group and 
Significant Others 
HS - Perceived Value 1 21 -3 9 1.4 1.9 3.3 
of Compliant Behaviour 2 43 0 13 6.1 6.1 2.7 5.42 p<.001 4.36 p<.001 co 
-.J 
Table. 25 (Continued) 
HS - Validation by 1 21 -5 15 
Significant Others 2 43 -5 40 
HS - Combined Effect 1 21 -8 24 
of Perceived Value 2 43 -1 53 
and Validation 
H6 - Combined Effect 1 21 18 136 
of all Hypotheses 2 43 20 185 
9.0 7.9 6.7 
11.0 11.2 6.8 
10 9.7 8.5 
17.8 17. 3 7.9 
86.0 76.2 33.8 














Two main types of analyses have been used in the 
testing of the study's hypotheses. These included: 
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testing for between group differences, and correlational 
testing for relationships between variables. These 
analyses highlight something different about each variable. 
When comparing variables between groups as the sole 
means of analysis, one is adopting the individualistic 
approach in testing for variables which differentiate 
compliers from noncompliers. Analyses indicate whether or 
not significant differences exist between groups. On the 
other hand, correlational analyses indicate whether or not 
a relationship exists, in this case, between one or more 
variables and reported noncompliance. 
Frequently throughout the results there are variables 
with statistically significant correlations with reported 
noncompliance, and results which are not significant in 
between group analyses of the same variable. It is proposed 
that because of the arbitrary fashion with which subjects 
in compliance studies are categorised as either compliers 
or noncompliers, this technique does not accurately account 
for the importance of variables in the overall problem of 
noncompliance. 
Reviewing methods of classifying compliers and non-
compliers Gordis (1979) mentions three particular methods. 
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These are: 1) spliting a sample on the basis of a biological 
decision, i.e. level of compliance necessary to achieve a 
therapeutic response, 2) statistical classifications where 
the median level of compliance in a group of patients is 
used as the discriminative variable amongst groups, and 
3) arbitrarily choosing a level of compliance as a discrim-
inative variable amongst groups. The third method was used 
in this study and is considered by Gordis to be the more 
common method. 
It is thought by the author that because these methods 
do not use a standardised level of noncompliance as a 
discriminative variable in differentiating compliant and 
noncompliant subjects, it is possible for the results of 
different studies to contradict one another unnecessarily 
when different levels of noncompliance are used to differentiate 
compliers and noncompliers. To overcome this problem and 
encourage consistency amongst findings it is proposed that 
the use of correlational analyses of variables being tested, 
should be supported. 
Since the design of this study incorporated the 
differentiation of compliant and noncompliant groups, 
between group analyses and correlational analyses have been 
reported and discussed in both the results and discussion 
sections. The group distinction has also allowed for: 
1) analysis of discrete variables which only allow for 
comparisons between groups, and 2) comparison of results 
with other study findings where applicable. 
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Hypothesis 1 
Although two of the first three variables individually 
correlated with reported noncompliance did not show 
significant results, it is interesting that the correlational 
analysis of the three variables combined did show a 
statistically significant negative relationship. However, 
the between group analysis of these three variables combined 
was not significant. 
Further correlational analyses indicated that neither 
complexity nor duration of medication regimens showed a 
significant relationship with reported noncompliance. The 
between group analysis also failed to show a difference. 
These findings contradict those of a number of studies 
which have reported group differences with these two 
variables. 
These final results may have been affected by two 
factors: 1) use of an insensitive measurement of complexity 
and duration, e.g._ the categorisation of duration into 
yearly categories would not have been as sensitive to smaller 
intervals as if the categories had represented monthly 
intervals. 2) Alternatively discrepant data affected by the 
use of a self-report measurement of compliance may have 
confounded the results. Nevertheless the confidence levels 
associated with the analyses of both variables were very low 
and it is questionable whether or not more accurate levels 
of noncompliance and subsequent differentiation of group , 
members would alter the confidence levels to any great extent. 
On the other hand it may be that complexity and 
duration of medication regimens are not important determinants 
of compliance for these subjects. A revision of studies 
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focusing upon these two variables indicate that in the 
majority of cases the populations sampled consisted of 
nonpsychiatric populations with nonpsychiatric conditions, 
e.g. compliance with medication for cardiovascular, 
tubercular, hypertensive and contraceptive problems, and 
medication compliance by outpatients of general medical 
wards, and amongst elderly people. 
An assumption was made that the interaction of the 
first three variables represented enactment of the at risk 
role. Based upon this assumption the finding that the 
combination of all five variables did not show a significant 
relationship with reported noncompliance, supported by the 
failure of the between group analysis to show a difference 
rejects the modified version of hypothesis 1. This 
hypothesised that knowledge in enacting the at risk role is 
likely to be associated with higher compliance, and that 
this is subsequently mediated through the complexity and 
duration of the medication regimen. 
Nevertheless, these findings may also have been 
affected by the same factors which possibly affected the 
findings of complexity and duration. 
The omission from the analysis of the variable 
'competency' does not enable an accurate examination of the 
original hypothesis to be made. However, until competency 
is operationally defined and measurable in an unobtrusive 
manner it is likely to remain untested. 
Hypothesis 2 
Assuming the interaction of personal attitudes towards 
having manic depression and susceptibility to manic depression 
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represents the extent to which the at risk role has been 
incorporated into the self-concept, the correlational 
analysis of the combined effect of these two variables 
support hypothesis two. These correlational findings are 
supported by a statistically significant difference between 
groups. Both findings are statistically significant and 
confirm the second hypothesis that compliance is maximised 
when there is evidence that the sick or at risk roles have 
been incorporated into the self-concept of the client. 
The finding that susceptibility to manic depression 
(insight) did not show a statistically significant 
difference between groups is contrary to past research 
findings by del Campo et al (1983) and Van Putten et al 
(1976). A possible reason for this contradiction may be 
due to different discriminating variables used by both 
studies in differentiating between the compliant and non-
compliant groups. 
The measurement of self-concept results showed no 
significant differences between groups although two 
statistically significant positive relationships were found 
between the potency and activity factors and reported 
noncompliance. The failure to replicate past factorial 
analyses of the three factors used, raises questions about 
the accuracy of any interpretation of the findings. 
Consequently no interpretation was attempted. It is thought 
that the failure to replicate past factorial analyses could 
have been affected by either the sample size being too 
small or possibly the sample. 
Despite the between group analyses of the MHLC scores 
which were not significant, the IHLC scores indicated a 
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statistically significant positive correlation with reported 
noncompliance. This contradicts the findings of Anderson 
et al (1982) and B.S. Wallston and Wallston (1978a) who 
reported that internally oriented individuals generally 
showed more compliant behaviour than externally oriented 
individuals. 
Although the findings from this study contradict the 
findings of other studies, it would appear realistic to 
propose that these findings may occur. It would appear 
feasible that compliance may be characterised by a predominant 
powerful others health locus of control (where upon an 
individual is compliant due to the influence of his or her 
doctor), while internal health loci of control were neither 
characteristic of compliance nor noncompliance. This is 
suggested since basically individuals with a predominant 
IHLC do as they please which may involve being either 
compliant or noncompliant. 
Hypothesis 3 
As found in the analysis of hypothesis one, once again 
a statistically significant negative relationship has been 
found between the combined effects of a number of variables 
and reported noncompliance, when less than half the 
contributing variables independently showed such a significant 
relationship. Nevertheless, assuming the four roles studied 
are typical of roles subjects are likely to find themselves 
in, the results confirm the hypothesis that compliance is 
enhanced when relevant other roles are congruent and/or 
complementary with client roles. 
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Amongst the four roles examined: doctor-patient 
relationship, work, family and living situation, satisfaction 
with living situation was the only one to show a statistically 
significant negative relationship with reported noncompliance. 
These findings suggest that the effects of the four roles 
interact to create a relationship with noncompliance which 
independently three of the four roles do not create. As 
the interactional model proposes it may be that the inter-
action of a number of variables is more important in 
determining compliance than investigation of individual 
variables. It also appears to indicate that what may appear 
to be an insignificant variable in determining compliance 
may become important in combination with other variables. 
The chi2 analyses performed in addition to the above 
tests found three notable results. 1) Contrary to Dietrich 
and Marton (1982), continuity of the doctor-patient relation-
ship determined by whether subjects had been patients of 
their doctor's for less than or longer than one year, did 
not differentiate compliers from noncompliers. Results may 
have been affected by unequal group differentiation between 
studies or limited response categories not sensitive enough 
to longer periods of time. However, as with the earlier 
findings of complexity and duration as determinants of 
compliance, the majority of studies which related to continuity 
of the doctor-patient relationship did not involve 
psychiatric disorders, e.g. compliance with: oral penicillin, 
pediatric, and hypertensive medication regimens. 2) Contrary 
to Korsch and her colleagues (as noted by Jay et al, 1984), 
the type of relationship subjects had with their individual 
doctor, e.g. authoritarian versus mutual, did not differen-
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tiate the two groups. 3) Contrary to Porter (1969) type of 
living situation did not differentiate the two groups and 
in particular living alone was not notably associated with 
the noncompliers. 
The results of the last two points may have been 
affected by unequal group differentiation between studies. 
Note is also made that Porter's (1969) study related to 
general practice patients on chronic medication. 
It was noticed in eatlier analyses that some data 
which have not shown statistically significant differences 
between groups have nevertheless shown statistically 
significant relationships with reported noncompliance. 
It is therefore unfortunate that due to the nature of the 
data being analysed within the chi2 analysis, testing was 
restricted to between group comparisons. 
Hypothesis 4 
Assuming that the influence of significant others 
coupled with participation or lack of it in a support group 
represents the degree of reinforcement by significant others 
and other reference group, the correlational analysis of 
the combined effects of both variables with reported non-
compliance confirms hypothesis four. Nevertheless caution 
is necessary when interpreting the results, e.g. although 
membership to a support group showed a statistically 
significant result when compared between the compliant and 
noncompliant groups, it is questionable whether or not such 
support groups actually encourage compliance or alternatively 
attract mostly compliant individuals. Further research is 
necessary to investigate this question. 
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The relative relationship of perceived helpfulness of 
support groups to reported noncompliance was statistically 
significant showing that the more helpful subjects found 
the support group, the more compliant they were likely to 
be. This was illustrated by the finding that both non-
compliant subjects who belonged to support groups did not 
find them helpful while in contrast only one of the twenty-
three compliant subjects did not find his or her group helpful. 
However, because the statistical analysis only refers to a 
correlational relationship between perceived helpfulness 
of support groups and reported noncompliance, no specific 
conclusions can be made other than to say that a statistically 
significant negative relationship exists between the two 
variables. 
Although the majority of subjects belonging to a group 
belonged to the Manic Depressive Society's support group, 
it was evident that there were a number of different groups 
available to people seeking help in coping with manic 
depression. 
Although the correlational analysis of the combined 
effects of the two variables confirms the hypothesis, the 
results from a between groups analysis of the same data were 
not significant. Considering that the focus of the 
statistical analysis was upon the correlational analyses of 
variables with reported noncompliance, the results confirm 
hypothesis four, that compliance is enhanced if the compliance 




Assuming that both the variables tested: 1) perceived 
value of compliance behaviours by the subjects, and 
2) validation of medication compliance by significant others, 
adequately represent the degree to which behaviours of 
compliance are judged valuable by the client and are 
validated by significant others, the statistical analysis 
confirms hypothesis five. 
As in many other instances, although the correlational 
analyses of both variables showed statistically significant 
negative relationships with reported noncompliance only one 
of the two variables, perceived value of compliance behaviours 
by the subject, showed a statistically significant difference 
between the two groups. 
Nevertheless both the correlational and between group 
analyses of the combined effect of both variables showed 
statistically significant results. This confirmed that the 
level and extent of a client's compliance with a health care 
regimen depends on the degree to which behaviours of 
compliance are judged valuable by the client and are 
validated by significant others. 
Hypothesis 6 
Hypothesis six proposed that all four components of 
role enactment: 1) compliance role enactment, 2) incorporation 
of role into self-concept, 3) counter roles, and 4) periodic 
evaluation of role, had to be present for compliance to occur. 
The dominant statistical analysis used to confirm or 
reject the other hypotheses has been the correlational 
analysis. However, the wording of this hypothesis appears 
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more suited to a between groups analysis where compliance 
is implied as either present or absent. Using the most 
appropriate form of analysis and based upon the assumption 
that statistically significant findings of a combination of 
variables constituting an hypothesis, confirm that hypothesis, 
the t-test used in this analysis confirmed hypothesis six. 
A correlational analysis performed also showed a 
statistically significant result indicating a strong negative 
relationship between the cumulative scores of all hypotheses 
and reported noncompliance. 
While both findings theoretically confirm hypothesis 
six, consideration of individual hypotheses does not. Based 
upon the assumption that confirmation of specific hypotheses 
subsequently confirm the presence of the applicable component, 
examination of the analyses of all prior hypotheses indicate 
that compliance role enactment as tested in hypothesis one 
was rejected by both between groups and correlational analyses. 
All other hypotheseswere confirmed by either the correlational 
and/or between groups analyses. 
This finding where the combined effect of two or more 
variables has shown a statistically significant result, when 
not all of the variables individually have shown such results 
has also been found in past correlational and between groups 
analyses. As before it is assumed that the combined effect 
of all the variables involved interact to create a 'variable' 
which in this case is closely related to reported noncompliance 
and distinguishes compliers from noncompliers, which not all 
the variables independently are able to do. 
The correlational coefficient derived was -.44. When 
squared (.1936), it provides an estimate of the degree of 
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variance of the dependent variable, accounted for by the 
independent variable assuming a linear relationship. In other 
words the combined effect of all variables considered in 
hypothesis six account for less than 20% of the variance of 
the reported noncompliance assuming a linear relationship. 
When considering the relatively large number of variables 
examined in this hypothesis, 20% of the variance still leaves 
a considerable amount of variance unaccounted for. 
Although not used it would have been interesting to 
have performed a multiple regression analysis upon the 
variables tested to examine which variables accounted for 
the greatest amount of variance. 
Based upon the assumption that this hypothesis underlies 
the interactional model, analysis of the data suggests a 
strong tendency for medication noncompliance to be affected 
by a number of interacting variables associated with role 
theory. However, it would be inappropriate to make any 
specific conclusions regarding validation of this model from 
this study considering no other reported studies have used it. 
Nevertheless the results produced appear to support the 
application of the interactional model to research of medica-
tion compliance and possibly health care compliance also. 
Reflecting upon this study's findings there is plenty of 
scope for additional research using this model. 
Sociodemographic Variables 
The sociodemographic variables analysed in this study 
found two variables: marital status and age which differ-
entiated the two groups with statistical significance. These 
were similar to the findings of Jamison and Akiskal (1983) 
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concerning the apparent effect of three sociodemograhpic 
variables upon lithium compliance. They reported that 
married individuals, females and increasing age amongst 
subjects tended to be associated with better compliance. 
Similarly, this study found being married was associated 
with better compliance but it also found that divorced, 
separated or widowed subjects also tended to be more 
compliant. Concerning age amongst subjects, the age period 
between 20 and 29 years was the most representative of non-
compliance while subjects 30 years and over were mainly 
compliant. Sex was not found to have any effect in 
distinguishing groups. 
The findings concerning marriage may be due to the 
influence of married subjects not wanting to disrupt their 
home life or alternatively may be due to having more super-
vision with respect to their medication taking. However, 
neither of these explanations adequately apply to subjects 
who are divorced, separated or widowed, who also had a 
tendency to be compliant. Nevertheless,· married subjects 
showed a considerably greater probability than either of 
these other groups, of being compliant. 
The tendency for single people to be noncompliant 
appears to be closely related to subjects in the 20-29 year 
age group who also showed a greater tendency to be non-
compliant. 
Compliance Variables 
Considering the focus upon studying compliance as a 
continuous variable it was unfortunate that analysis of 
Kucera-Bozarth's self-report compliance questionnaire was 
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restricted to a chi
2 
analysis. Nevertheless, with considera-
tion to the validity of this questionnaire it was encouraging 
that each question as presented in its modified form showed a 
statistically significant difference between the two groups. 
As a method of measurement however, it remains limited by its 
dependency upon self-report. It requires further studies to 
help validate it as a measurement technique. In the meantime, 
where available, it would be beneficial to include other more 
objective methods of measurement in addition to this 
questionnaire when measuring noncompliance. 
The non-significant finding between groups of time, 
since subjects had their serum lithium levels last tested 
suggests that compliant subjects tend to overlook having blood 
tests as often as noncompliant subjects. Although results 
may have been affected by the dichotomous categorisation of: 
three months and over, or under three months, used when 
classifying subjects this was chosen because of the three 
monthly blood tests recommended to most lithium users. 
Findings from the analysis of whether or not subjects 
had been previously noncompliant showed significant results. 
The findings indicated that the majority of compliant subjects 
had never been noncompliant while the majority of noncompliant 
subjects had been noncompliant more than once before. These 
findings support the suggestion by Jamison and Akiskal (1983, 
p.179), that two major types of manic depressives appear to 
exist: 1) those who would never consider being noncompliant 
and never have been, and 2) those who have been, and will 
probably continue to be occasionally noncompliant. 
Individual awareness of consequences of lithium non-
compliance also showed a statistically significant difference 
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between groups. Results indicated that subjects who had 
developed some conscious insight into the detrimental 
consequences that may be associated with noncompliance were 
more likely to be compliant while the opposite was the case 
for noncompliers. Nevertheless it is apparent from the 
results that this is not enough by itself to ensure compliance. 
Summary of results 
This section summarises the findings of the study in 
order of the six hypotheses tested and finished with conclusions 
regarding these findings. 
This study found significant negative correlations 
between a number of individual and combined variables, and 
reported noncompliance. The following conclusions were made 
in respect to these findings. 
Hypothesis l rejected, that knowledge in enacting the 
at risk role is likely to be associated with higher compliance, 
which is subsequently medicated through the complexity and 
duration of the medication regimen. 
Hypothesis 2 confirmed, that compliance is maximised when 
there is evidence that the sick or at risk role has been 
incorporated into the self concept of the client. 
Hypothesis 3 confirmed, that compliance is enhanced 
when relevant other roles are congruent and/or complementary 
with client roles. 
Hypothesis 4 confirmed, that compliance is enhanced 
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if the compliance role is reinforced by significant others 
and other reference groups. 
Hypothesis 5 confirmed, that the level and extent of a 
client's compliance with a health care regimen depends on the 
degree to which behaviours of compliance are judged valuable 
by the client and are validated by significant others. 
Hypothesis 6 found that the combined effect of all 
variables showed a statistically significant negative 
relationship with reported noncompliance, confirming 
statistically that all four components of role enactment 
have to be present for compliance to occur. However, when 
individually examined, compliance role enactment as tested 
in hypothesis one was not present. 
A number of additional issues not directly related to 
the six hypotheses but pertinent to the study, such as MHLC, 
self-concept and continuity of DPR, although not mentioned 
in this summary were investigated. For information on the 
findings regarding these issues the reader should consult 
the relevant parts of the discussion section. 
Methodological considerations 
The results of this investigation into lithium compliance 
amongst manic depressives need to be viewed with some caution 
given the following methodological limitations: 1) use of 
self-report for the majority of information collected which 
may have introduced a number of contaminating factors, 2) the 
large number of assumptions made about variables without 
adequate validation, and 3) use of a selective sample. 
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Although some of these limitations, i.e. lack of 
validation, may be improved upon in future research, other 
problems in the study are characteristic of research in this 
area, e.g. lack of accurate measurements of compliance, and 
need to be accepted as such. 
For obvious reasons it was desired to compare the 
findings of this study with the findings of other relevant 
studies. Unfortunately the operational definitions used in 
the studies frequently differed creating problems for such 
comparisons. To overcome this problem both correlational 
,.I 
and between groups analyses were applied. At times this 
created confusion in that a firtd~ng was occasionally 
significant under one form of analysis and not under the 
other. To some extent this limited the clarity of conclusions 
that could be made. 
It is hoped that this study will provide a basis for 
future research into lithium compliance by manic depressives. 
The findings of some hypotheses have been affected by lack of 
an adequate definition by Dracup and Meleis (1982) and future 
research to study this model will also no doubt be affected 
by it. 
A suggestion which may assist future researchers is to 
use a sample large enough to allow for differential testing 
between different levels of noncompliance. This would help 
to avoid the problems caused by the lack of a standardised 
cut-off point between compliance and noncompliance. 
Conclusion 
This study has found that while some individual variables 
may not show significant correlations with compliance/non-
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compliance of medication, when combined, many of these same 
variables do show significant correlations. This provides 
strong support for the use of an interactional model in 
the study of medication compliance. 
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INTRODUCTORY LETTER Department of Psychology 
University of Canterbury Christchurch 1 New Zealand 
Dear 
38 Plynlimon Road, 
Bryndwr, 
Christchurch 5. 
25 August 1984 
Greetings. My name is Fiona Macintyre, and I am a trainee 
psychologist. I have been involved in the area of manic depression 
for the past l½ years, during which time I have talked to many 
individuals with the disorder. 
At present I am involved in a study which you may be interested 
in helping me with. I am studying the effects of manic depression 
on people's lives, looking in particular at individual attitudes 
towards the disorder, the attitudes of others towards those with 
manic depression, and different aspects of medication associated 
with manic depression. I am especially interested in contacting 
individuals who are presently being prescribed lithium, either 
by itself or in combination with other medication. This 
includes people with both favourable and unfavourable impressions 
of lithium. 
If you feel you could help, I would be very grateful to hear from 
you and will, be happy to answer any questions you may have. My 
telephone number is---- and if there is no reply, I may be 
contacted at~-- where a message may otherwise be left. 
Thankyou very much for your help and attention. 
Yours faithfully, 
Fiona R. Macintyre (Miss) 
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APPENDIX 2 
Department of Psychology 
University of Canterbury Christchurch 1 New Zealand 
MEASUREMENT OF SELF-CONCEPT 
The purpose of this study is to learn more about manic depression. 
This includes studying personal attitudes towards the disorder, effects 
it has on people's lives and factors which may affect the disorder 
itself. 




examines how individuals see themselves. 
examines individual attitudes, families, 
aspects of medication and attitudes of 
others towards those with manic depression. 
examines more personal attitudes towards 
health. 
CONFIDENTIALITY : Answers from all questionnaires are kept strictly 
confidential. No individual names are required on the questionnaires 
and no names will be used in reporting the results. 
CONSENT: Due to the nature of this research it may be necessary to 
contact individual doctors to obtain confirmation of admission dates 
to hospital, specific medication information and possibly other 
relevant information. In the case of such a necessity, written consent 
from the individual concerned is re~uired. This can be given by 
signing the statement below. 
I am very grateful to everyone who has agreed to participate in 
this study. Thank you very much for your time and co-operation. 
Fiona Macintyre. 
I have read about the purpose of this study and understand the 
answers are completely confidential. I also understand the possible 
necessity to obtain relevant information from my doctor and agree to 
give my consent to this. 
Signature Date 
INSTRUCTIONS FOR SECTION A 
The purpose of this first study is to get a better understanding of 
how you perceive yourself (you as you really are). It requires you to rate 
yourself against a series of descriptive scales. 
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On the next page are numerous scales on which to rate yourself as 
accurately as possible. If you feel that you are very closely characterised 
by one end of the scale, you should place your check mark as follows: 
FAIR X : . . . . . . . . . . UNFAIR -------
OR 
FAIR . . . . . . . . . . : X UNFAIR -------
If you feel you are quite closely characterised by one or the other 
end of the scale (but not extremely), you should place your check mark as 
follows: 
STRONG . . . . . . . . : X : WEAK --------
OR 
STRONG . . . . . . . . : X : WEAK -------
If you are only slightly characterised by one side as opposed to the 
other side (but are not really neutral), then you should check as follows: 
ACTIVE : : X : : : : PASSIVE -------
OR 
ACTIVE : : : : X : : PASSIVE ------·---
The direction toward which you check, of course, depends upon which of the 
two ends of the scale seem most characteristic of you. 
If you consider yourself to be neutral on the scale, both sides of 
the scale are equally characteristic of you, or if the scale is thought 
to be completely irrelevant and unrelated to you, then you should place 
your check mark in the middle space: · 
SAFE : : : X : : : DANGEROUS -------
IMPORTANT: 
1. Place your check marks in the middle of spaces, not on the boundaries: 
Not 
This This 
: : : X : : ~ -------
2. Be sure you check every scale - do not omit any. 
3. Never put more .than one check-mark on a single scale. 
4. Remember to rate yourself according to your real self, 
























ME (AS I REALLY AM) 
. . . . . . . . . . . . --------
. . . . . . . . . . . . -------
. . . . . . . •. . . . . -------
~ . . . . . . . . . . . -------
. . . . . . . . . . . . -------
. . . . . . . . . . . . --------
. . . . . . . . . . . . -------
. . . . . . . . . . . . -------
. . . . . . . . . . . . -------
. . . . . . . . .. . . . -------
. . . . . . . . . . . . -------
. . . . . . . . . . . . -------
. . . . . . . . . . . . -------· 
. . . . . . . . . . . . -------
. . . . . . . . . . . . ------- .. 
. . . . . . . . . . . . -------
. . . . . . . . . . . . -------
. . . . . . . . . . . . . -------
. . . . . . . . . . . . -------· 
. . . . . . . . . . . . . -------· 
. . . . . . . . . . . . -------
. . . . . . . . . . . . -------


























SCORING PROCEDURE FOR THE MEASUREMENT 
OF SELF-CONCEPT 
Each scale included in the measurement of the 
self-concept instrument represents the measurement of 
either an evaluative (E), potency (P) or activity (A) 
factor. The representation of each scale is expressed 
down the left hand side of the instrument. 
Scoring involved assigning a numerical score between 
1 and 7 inclusive, to each of the 23 scales. The score 
attributed to the subject's position on the scale is 
determined by the extreme scores featured at both 
ends of each scale. 
Factorial scores represented the accumulated scores 







































ME (AS I REALLY AM) 
6 5 4 3 2 1 
_7_:_:_:_:_:_:___1_ 
1: : : : : : 7 -------
7 : 1 -------
1: 7 -------
1: 7 -------
7 : 1 -------
_l_:_ -· - -·- _7_ 
7 : 1 -------
1: 7 -------
7 : ·, . 1 
-------
1: 7 -------
7 : . 1 -------
7 : 1 
-------· 
1: 7 -------
7 : 1 ------- .. 
1: 7 
-------
7 : 1 
-------
7 : 1 -------
(E) , UNSUCCESSFUL 1 : 7 
-------· 
(P) STRONG 7 : 1 
---·----· 
(E) SELFISH 1: 7 -------
(A) EXCITABLE 7 : • • 1 -------
(E) UGLY 1. 7 
-------
2 3 4 5 6 
























APPENDIX 4 _____ ._ 
MEASUREMENT OF ATTITUDES AND MEDICATION COMPLIANCE 
The purpose of this second section is to learn more about individual 
attitudes towards having manic depression, attitudes of others towards 
those with manic depression in addition to gaining more information about 
aspects of medication. 
Please try and answer all questions according to the directions 
given. If you are unsure or unclear about a question or how to answer it, 
please ask me to explain. 
Please answer all questions as honestly as you can, as this is 
especially important for the study. All answers are STRICTLY CONFIDENTIAL. 
1. .What is your marital status? (tick appropriate box) 
( ) single 
( ) married 
( ) divorced, separated, wtdowed 
2. What is your sex? 
male 
female 
3. What is your age? 
( ~ under 20 years 
( ) 20 - 29 years 
( ) 30 - 39 years 
( ) 40 - 49 years 
( ) 50 years and over 
4. Who is there in your .. i.mmedfate.family? 
5. Are you employed in either a voluntary or paid job? 
( yes - paid 
(. ) yes - voluntary 
( no 
If yes, what is your job? 
121 
6. How important is this job to you? (mark 1 space according to degree 
of importance) 
. . . . . . 




7. Highest level of education, either fully or partially completed (tick 1) 
( . ) primary (up to form 3) 
( ) secondary (form 3 to form 7) 
( ) school certificate 
( ) . university entrance 
( ) bursary or scholarship 
( ) tertiary (education beyond secondary school) 
if tertiary please specify 
8. Have any other family members or relatives been diagnosed as having 
manic depression? 
( ) yes 
( ) no 
( ) don't know 
If yes, please specify which relatives, e.g. father. 
9 .. How long ago were you told you had manic depression? 
( ) under 1 year 
( ) 1 - 2 years 
( ) 2 - 3 years 
( ) over 3 years 
10. When were you last admitted to hospital because of your manic depression? 
11. How long were you in hospital during your last admission? 
12. What do you think is the likelihood of your experiencing an episode 













13. What do you think is the likelihood of your experiencing an episode 




( don't know 
14. How many lithium are you taking each day? e.g. 1 three times daily. 
15. How many different types of pills, prescribed by your doctor, do you 
take daily? 
( ) one 
( ) two 
( ) three or more 
( ) don't know 
16. How frequently do you have to take each type of pill? (Make one 
tick for each type). 
once a day 
twice a day 
three or more times a day 
don't know 
17. How long have you been on lithium since the first time you 
were prescribed it? 
( ) less than a year 
( ) 1 - 2 years 
( ) 2 - 3 years 
( ) over three years 
( ) don't know 
.... Question 18 
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18. Are there any reasons you might not follow your doctor's advice 
to take lithium? 
yes 
no 
If yes, please tick the reasons that are applicable: 
( ) unpleasant side effects 
( ) not satisfied with my doctor 
( ) I don't understand why I should take it 
( ) I don't think I need it anymore 
( ) I don't think it works for me 
( ) It is too complicated to take 
( ) I sometimes forget to take it 
( ) My family or friends convince me I don't need it 
( ) It slows me down too much 




I have difficulty getting my prescriptions filled 
I don't like having any blood samples taken off 
Other (please specify) 
19. How do you find having to take lithium daily? 
.. . . . . . ----
not extremely 
bothersome bothersome 
20. Does it bother you that your moods could be controlled by lithium? 
( yes 
. ( no 
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21. How do you find talking to other people about having ~anic depression? 





22. How does the idea of returning to hospital make you feel? 





23. How easy have you found it to accept that you have manic depression? 





24. What doctor(s) have you been seeing in the last 12 months about 
your manic depression - discussing the disorder, getting 
prescriptions etc. (Please write names and locations) 
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If more than one, who is the more important to you regarding treatment 
of your manic depression. 
25. How long have you been a patient of his/hers? 
( ) less than 1 year 
( ) longer than 1 year 
( ) don't know 
The next questions 26-36 refer to the doctor most important to you for 
your manic depression. 
26. Tick five words which best describe your doctor's attitude towards you. 
( ) cold 
( ) good natured 
( ) helpful 
( ) indifferent 
( ) insincere 
( ) obliging 
( ) impatient 
( ) reassuring 
( ) rejecting 
( ) respectful 
( ) superficial 
( ) sympathetic 
( ) understanding 
( ) unfriendly 
( ) unsupportive 
( ) warm 
27. Tick five words which best describe your doctor's treatment of your 
manic depression? 
( ) attentive 
( ) competent 
( ) confident 
( ) efficient 
( ) ignorant 
( ) inattentive 
( .) incompetent 
( ) inefficient 
( ) inexperienced 
( ) knowledgeable 
( ) proficient 
( ) skilled 
( ) slack 
( ) sloppy 
( ) thorough 
( ) unskilled 
28. What degree of support and encouragement does your doctor give you 








29. How much confidence do you have iri your doctor? 
. . . . . . ----
no 
confidence 
a great deal 
of confidence 
30. Does your doctor spend enough time with you at each consultation? 
( yes 
( no 
31. How satisfied are you with the level of communication between your 
doctor and yourself? 





32. After talking to your doctor about your problems, how satisfied 
are you with the amount of feedback he gives you? 





33. How approachable has your doctor been when you have wanted to discuss 
your lithium, e.g. side effects etc. 





34. Does your doctor explain instructions to you clearly, making sure 
you understand them? 
( ) always 
() usually 
( ) never 
35. Which description best describes the relationship you have with 
your doctor? 
your doctor takes the major responsibility for any 
decisions made and your responsibility.is in co-
operating with these decisions 
both your doctor and yourself have approximately 
equal responsibility in any decisions made 
36. Are you satisfied with this relationship? 
( ) Yes 
( ) No 
37. If you are working in a job, whether paid or voluntary, what do 





( ) my job would probably be kept open for me 
. ( ) my job probably would not be kept open for me 
( ) other ( please specify) 
( ) N/A 
What is your current living situation? 
( ) live by yourself 
( ) live with other family members 
( ) live with others (not family) e.g. flatting 
( ) other (please specify) -----------------
Are you satisfied with your current living situation? 
( yes 
( no 
Do the others you live with know you have manic depression? 
( ) yes 
( ) no 
( ) some 
( ) N/A 
41. In general what degree of support for your manic depression do you 
receive from those you live with? 
N/A 
. . . . . . ----
no 
support 
a great deal 
of support 
42. What effect would it have on your present living arrangements if 
you experienced an episode of mania? 
. . . . . . ----
not 
disruptive · · 
extremely 
dist11ptive 
43. What effect would it have on your present living arrangements if 
you experienced an episode of depression? 





44. What degree of support for your manic depression do you receive 
from family members. 
N/A 
. . . . . . ·----
no 
support 
a great deal 
of support 
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45. What effect would it have on your family if you experienced an 
episode of mania? 
N/A 





46. What effect would it have on your family if you experienced an 
episode of depression? 
47. 
48. 
Do you belong to 
( yes 
( no 
. . . . . . ----
not 
disruptive 
a support group 
extremely 
disruptive 
for your manic 
If yes, what is it's name (please specify) 
How long have you been a member of it? 
( ) less than 6 months 
( ) 6 months to 1 year 
( ) 1 - 2 years 
( ) over 2 years 
( ) N/A 
depression? 
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49. How frequently does your group meet? (Please specify) --------
( N/A 
50. How frequently do you attend? 
( at least twice out of every three meetings 
( about once every two meetings 
( less frequently than once every two meetings 
( N/A 
51. How well do you feel the meetings help you cope with your manic depression? 
N/A 





52. The term 'significant other' is applied to someone who is important 
to you and influences your behaviour in either a positive or negative 
way. · Label up to 5 people who you consider to be a significant 
other in your life, using the letters A, B, C, D & E. (The letters 





Sister(s) Support Group Members 
Brother( s) Children 
Boss Flatmate(s) 
Fellow workers Other (specify) 
Friend(s) 
53. What degree of support and understanding does each person provide 
you with? (Put letter of each significant other beside appropriate 
response. More than orie letter can be put beside each choice). 




54. Where does each person stand with respect to checking whether or 
not you take your lithium? 
they nag me about it 
they often ~sk if I have taken it 
they ask questions only if they feel something 
is different · 
they don't ask questions, but leave the responsibility 
for ta k i n g my p il 1 s up to me . 
they don't .know I have manic depression 
other (please specify) 
55. How noticeable would it be to each person if you had not taken your 













57. What is your personal feeling towards the use of medication for treating 
psychological disorders? 




neutra 1 strong 
personal 
liking 
58. What part does medication play in helping you cope with manic depression? 





59. In the last two weeks, have you ever missed a dose of lithium? 
( ) no 
( ) yes 
If yes, how many times? ------------
60. In the last two weeks, have you always taken your lithium at the 
times of day you were instructed? 
( no 
( ) yes 
61. In the last two weeks, have you taken the number of lithium 
prescribed each day? 
( ) no 
( ) yes 
If no, did you take more? ) or less? 
62. How important is it to you to take your medication as directed 
by your doctor? 





63. When did you last have a blood test to check your lithium levels? 
( ) within the last 2 weeks 
( ) 2 weeks - 3 months ago 
( ) over 3 months ago 
64. Have you ever taken yourself off lithium without your doctor's 
knowledge? 
( ) yes 
( ) no 
If yes, how many times have you done this? 
If yes, for how long on average? 
65. When did you do this? 
( ) N/ A 
66. What were the general consequences of having done this? 
( ) N/ A 
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APPENDIX 5 
SCORING PROCEDURE FOR 
MEASUREMENT OF ATTI-TUDES A.ND MEDICATION COMPLIANCE 
Responses to questions in Section B were scored 
according to the values assigned to each option as set 
out below. With reference to Table 1, the scores of 
appropriate questions were added together to represent 
variables which were ultimately used in group comparisons 
and correlational analyses. The discrete data produced 
were compared between groups. 
In accordance with the specific hypothesis being 
tested the scores were arranged so that the greater the 
positive score the greater the likelihood of the subject 
being compliant. Similarly the smaller the score the 
greater the likelihood of the subject being noncompliant. 
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SECTION B 
The purpose of this second section is to learn more about individual 
attitudes towards having manic depression, attitudes of others towards 
those with manic depression in addition to gaining more information about 
aspects of medication. 
Please try and answer all questions according to the directions 
given. If you are unsure or unclear about a question or how to answer it, 
please ask me to explain. 
Please answer all questions as honestly as you can, as this is 
especially important for the study. All answers are STRICTLY CONFIDENTIAL. 
1. .What is your marital status? (tick appropriate box) 
( 1 ) single 
( 2) married 
( 3) divorced, separated, widowed 
2. What is your sex? 
( 1 ) male 
( 2 ) female 
3. What is your age? 
( 1 ~ under 20 years 
( 2 ) 20 - 29 years 
( 3 ) 30 - 39 years 
( 4 ) 40 - 49 years 
( 5 ) 50 years and over 
4. Who is there in your i.mmediate. family? 
wife (1) husband (2) N/A CO) 
No. of children 
No. of parents, including inlaws 
No. of brothers and sisters, including inlaws 
5. Are you employed in either a voluntary or paid job? 
(2) yes-paid 
( l) yes - voluntary 
( O ) no 
If yes, what is your job? 
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6. How important is this job to you? (mark 1 space according to degree 
of importance) 
-2:1:2: 3 
not-. - -extremely 
important important 
( O) N/ A 
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7. Highest level of education, either fully or partially completed (tick 1) 
( 1) primary ( up to form 3) 
( 2) secondary (form 3 to form 7) 
( 3) school certificate 
( 4) . university entrance 
( 5) bursary or scholarship 
( 6) tertiary (education beyond secondary school) 
if tertiary please specify 
8. Have any other family members or relatives been diagnosed as having 
manic depression? 
( 1 ) yes 
( 2 ) no 
(0) don 1 tknow 
If yes, please specify which relatives, e.g. father. 
9. How long ago were your told you had manic depression? 
( 1 ) under 1. year 
( 2 ) 1 - 2 years 
( 3 ) 2 - 3 years 
( 4 ) over 3 years 
* 10. When were you last admitted to hospital because of your manic depression? 
(l) 0-lyr.ago (2) 1-2 yrs.ago. (3) over 2 yrs.ago. (0) don't know 
* 11. How long were you in hospital during your last admission? 
(1) 0-1 mth, (2) 1-3 mths, (3) 3-6 mths, (4) over 6 mths. (0) don't 
know 
12. What do you think is the likelihood of your experiencing an episode 
of either mania or depression if you don't take lithium? 
(3) high 
( 2 ) average 
( 1 ) low 
( 0 ) don I t know 
* Responses to these questions were confirmed with medical records. 
13. What do you think is the likelihood of your experiencing an episode 
of either mania or depression when you do take lithium? 
( 1) high 
( 2 ) average 
( 3 ) low 
(0) don'tknow 
** 14. How many lithium are you taking each day? e.g. 1 three times daily. 
_Knowledge Score 2 if correct 0 if wrong or don't kDOW 




types-of pills, prescribed by your doctor, do you 
Knowledge Score 
(-2) two 
(-3) three or more 
( o) don't know 
2 if correct 
0 if wrong or don't know 
* 16. How frequently do you 
tick for each type). ** 
have to take each type of pill? (Make one 
Complexitv Scare 
-1 once a aay 
-2 twice a day 
-3 three or more times a day 
0 don't know 
Knowledge Score 
·2 if correct 
1 if wrong or don't know 
17. How long have you been on lithium since the first time you 
were prescribed it? 
( . 4) le~s than a year 
( 3) 1 - 2 years 
( 2) 2 - 3 years 
( 1) over three years 




When scoring allow a number for each type of pill mentioned. 
Responses to these questions were confirmed with medical 
records. 
. ... Question 18 
18. Are there any reasons you might not follow your doctor 1 s advice 
to take l i th i um? 
( o ) yes 
( 2 ) no 
If yes, please tick the reasons that are applicable: 
( ) unpleasant side effects 
( ) not satisfied with my doctor 
( ) I don 1 t understand why I should take it 
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( ) I don 1 t think I need it anymore -1 point for each 
tick 
( ) I don 1 t think it works for me 
( ) It is too complicated to take 
( ) I sometimes forget to take it 
( ) My family or friends convince me I don 1 t need it 
( ) It slows me down too much 
( ) I miss my highs 
( ) I have difficulty getting my prescriptions filled 
( ) I don 1 t like having any blood samples taken off 
( ) Other (please specify) 
19. How do you find having to take lithium daily? 
3 : 2: 1 : 0 
not extremely 
bothersome bothersome 
20. Does it bother you that your moods could be controlled by lithium? 
( o ) yes 
. ( 2 ) no 
21. How do you find talking to other people about having manic depression? 











23. How easy have you found it to accept that you have manic depression? 






24. What doctor(s) have you been seeing in the last 12 months about 
your manic depression - discussing the disorder, getting 
prescriptions etc. (Please write names and locations) 
If more than one, who is the more important to you regarding treatment 
of your manic depression. 
25. How long have you been a patient of his/hers? 
( 1) less than 1 year 
( 2 ) longer than 1 year 
( O ) don I t know 
The next questions 26-36 refer to the doctor most important to you for 
your manic depression. 































1 point for each 
positive descrip 
tion and none for 
understanding negative descrip-
unfri endl y tions. 
unsupportive 
warm 
Tick five words which best describe your doctor's treatment of your 
manic depression? 
( ) attentive 
( ) competent 
( ) confident 
( ) efficient 
( ) ignorant 
( ) inattentive 
( ) incompetent 



























none for negative 
descriptions. 
28. What degree of support and encouragement does your doctor give you 
for your manic depression? 






29. How much confidence do you have in your doctor? 
0 : 1: 2 : 3 
no 
confidence 
a great deal 
of confidence 
30. Does your doctor spend enough time with you at each consultation? 
( 1) yes 
( o) no 
31. How satisfied are you with the level of communication between your 
doctor and yourself? · 





32. After talking to your doctor about your problems, how satisfied 
are you with the amount of feedback he gives you? 





33. How approachable has your doctor been when you have wanted to discuss 
your lithium, e.g. side effects etc. 





34. Does your doctor explain instructions to you clearly, making sure 
you understand them? 
(1) always 
( O) usually 
(-1) never 
35. Which description best describes the relationship you have with 
your doc tor? 
( l) your doctor takes the major responsibility for any 
decisions made and your responsibility is in co-
operating with these decisions 
( 2) both your doctor and yourself have approximately 
equal responsibility in any decisions made 
36. Are you satisfied with this relationship? 
( 2) Yes 
( 0) No 
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37. If you are working in a job, whether paid or voluntary, what do 
you think the consequences would be if you were hospitalised for 
your manic depression? 
my job would probably be kept open for me 
my job probably would not be kept open form~ 
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(-2) 
. ( 2) 
( ) 
( 0) 
other ( please specify) _c_o_d_e_a_c_c_o~r~d=i=·n~g-'-'-ly-'----------
N/A 
38. What is your current living situation? 
( 1) live by yourself 
( 2) live with other family members 
( 3) live with others (not family) e.g. flatting 
( ) other (please specify) Code accordingly 
39. Are you satisfied with your current living situation? 
( 2) yes 
( O) no 
40. Do the others you live with know you have manic depression? 
( 3) yes 
( 2) no 
( 1) · some 
( O) N/ A 
41. In general what degree of support for your manic depression do you 
receive from those you live with? 
( O) N/ A 
-1 : 1 : 2 : 3 
no 
·support 
a great deal 
of support 
42. What effect would it have on your present living arrangements if 
you experienced an episode of mania? 





43. What effect would it have on your present living arrangements if 
you experienced an episode of depression? 





44. What degree of support for your manic depression do you receive 
from family members. 
( o ) N/ A 
-1 : 1 : 2 : 3 
no 
support 
a great deal 
of support 
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45. What effect would it have on your family if you experienced an 
episode of mania? 
not 
( O ) N/ A di srupth'e 
extremely 
disruptive 
46. What effect would it have on your family if you experienced an 
episode of depression? 
(0) N/A 
- 1 : ___l_: _2_: L 
not 
disruptive 
-extr.eme 1 y 
disruptive 
47. Do you belong to a support group for your manic depression? 
( 2 ) yes 
( O ) no 
If yes, what is it's name (please specify) (1) M.D.S. 
48. How long have you been a member of it? 
( 1 ) less than 6 months 
(2) A.A. 
(3) GROW 




( 2 ) 6 months to 1 year (5) Church Group 
( 3 ) 1 - 2 ye a rs 
( 4 ) over 2 years 
( o ) N/ A 
How frequently does your group meet? (Please specify) (1) 
. ( 0 ) N/A 
How frequently do you attend? 
( 3 ) at 1 east twice out of every three meetings 
( 2 ) about once every two meetings 
(l) less frequently than once every two meetings 




two or more 




51. How well do you feel the meetings help you cope with your manic depression? 
-1 : l : 2 : 3 
52. 




he 1 pfu 1 
The term '.significant other' _is applied to someone who is important 
to you and influences your behaviour in either a positive or negative 
way. · Label up to 5 people who you consider to be a significant 
other in your life, using the letters A, B, C, D & E. (The letters 
do not indicate any particular order). 
Mother Boyfriend 
Father Girlfriend 
Husband Doctor Scoring: 
Wife Psychologist 
Sister(s) Support Group Members 
Brother(s). Children 
Boss Flatmate(s) 
Fellow workers Other (specify) 
Friend(s) 




53. What degree of support and understanding does each person provide 
you with? (Put letter of each significant other beside appropriate 
response. More than one letter can be put beside each choice). 
3 a great deal of support 
2 some support 
1 little support 





Add up each individuaJ 
to a maximum score 
and minimum score 
54. Where does each person stand with respect to checking whether or 
not you take your lithium? 
Scoring: Add up each individual 
55. 
56. 
1 they nag me about it letter to a max.of 5 and. 
1 they often ask if I have taken it min· of O • 
they ask questions only if they feel something 
1 is different · 
they don't ask questions, but leave the responsibility 
Ofor taking my pills up to me. 
O they don't .know I have manic depression 
other (please specify) code accordingly 
How noticeable would it be to each person if you had not taken your 
lithium for 5 days? 
3 extremely noticeable 
2 quite noticeable 
1 sl i.ghtly noticeable 
-1 not noticeable 
O don't know 
Scoring: The same as 
Question 53 
How important do you think it is to each person that you take your 
lithium regularly? 
3 extremely important 
2 quite important 
1 slightly important 
-1 not important 
Scoring: The same as 
Question 53 
57. What is your personal feeling tqwards the use of medication for treating 
psychological disorders? 







58. What part does medication play in helping you cope with manic depression? 






59. In the last two weeks, have you ever missed a dos~ of lithium? 
( o) no ~ Scoring: once number of missed pills is 
------ determined, using question 14, the level 
( ) yes of noncompliance is expressed as a 
If yes, how many times? _p_e_r_c_e_n_t_a_g_e_. _____ _ 
60. In the last two weeks, have you always taken your lithium at the 
times of day you were instructed? 
( O ) no 
(2 ) yes 
61. In the last two weeks, have you taken the number of lithium 
prescribed eac~ day? 
)' no 
( 2) yes 
If no, did you take more?· (1 ) or less? ~l) 
62. How important is it to you to take your medication as directed 
by your doctor? 





63. When did you last have a blood test to check your lithium levels? 
( 2 ) within the last ioo~tl:t 2 weeks 
( 2 ) E¾X::flWRtm&::ag~ 2 weeks - 3 months ago 
( O ) over 3 months ago . 
64. Have you ever taken yourself off lithium without your doctor's knowledge. 
( 0 ) yes 
( 2 ) no 
If yes, how many times have you done this? 
(1) once 
(2) more than once 
( O) N/ A 
If yes, for how long on average? 
(1) 1 weeks or under 
(2) over 1 week 
( 0) N/ A 
65. When did you do this? 
(0) N/A (3) prior to this last year as well as during the year 
(2) within last year only 
(1) over 1 year ago and not ~ince. 
66~ What were the genera~ consequences of having done this? 
( 0) N/ A 
(1) Showed no awareness of detrimental consequences 
(2) Recognised the detrimental consequences of noncompliance. 
APPENDIX 6 
KUCERA - BOZARTH SELF-REPORT 
SELF-REPORTED LITHIUM COMPLIANCE QUESTIONNAIRE 
In the last two weeks, 
1. Did you ever miss a dose of lithium? 
No 
Yes 
If yes, how many times? 








If no, did you take more? or less? 
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4. Are there any reasons you might not follow your 
doctor's advice to take lithium? 
No 
Yes 
If yes, please check the reasons: 
unpleasant side-effects 
not satisfied with my doctor 
costs too much 
I don't understand why I should take it 
( I don't think I need it anymore 
I don't think it works for me 
it is too complicated to take 
( inconvenient outpatient clinics 
my family or friends convince me I 
don't need it 
( it slows me down too much 
I miss my "highs" 
( difficulty getting my prescriptions 
filled 





5. Lithium has been effective as a medication in my 
treatment. (Circle the number that best describes 
your opinion.) 
1 2 3 4 5 6 
strongly moderately mildly mildly moderately strongly 
agree agree agree disagree disagree disagree 
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MULTIDIMENSIONAL HEALTH LOCUS OF CONTROL SCALES 
The purpose of this third section is to learn more about individual attitudes 
towards health. In particular I would like to know what you think may or 
may not influence your health. 
This questionnaire is a list of 18 brief statements. You choose a response 
to each statement that best describes how you feel about that statement. 
The response choices range from 'strongly disqgree' (scored as 1) to 
'strongly agree' ( scored as 6). Ci rel e the number that best describes 
what you think now. Obviously, there are no right or wrong answers. 




If I get sick it is 








my own behaviour which determines how soon I 
3 4. 5 6 
mildly mildly moderately strongly 
disagree agree agree agree 




4 5 6 
mildly moderately strongly 
agree agree agree 
Having regular contact with my physician is the best way for me 
to avoid illness. 
1 2 3 4 5 6 
strongly moderately mildly mildly moderately strongly 
disagree disagree disagree agree agree agree 
4. Most things that affect my health happen to me by accident. 
1 2 3 4 5 6 
strongly moderately mildly mildly moderately strongly 
disagree disagree disagree agree agree agree 
5. Whenever I don't feel well I should contact a medically trained 
professional. 
1 2 3 4 5 6 
strongly moderately mildly mildly moderately strongly 
disagree disagree disagree agree agree agree 
6. I am in control of my health. 
1 2 3 4 5 6 
strongly moderately mildly mildly moderately strongly 
disagree disagree disagree agree agree agree 
7. My family has a lot to do with· my becoming sick or staying healthy. 
1 2 3 4 5 6 
strongly moderately mildly mildly moderately strongly 
disagree disagree disagree agree agree agree 




















1 2 3 4 5 
strongly moderately mildly mildly moderately 













My good health is largely a matter of fortune. 
1 2 3 4 5 
strongly moderately mildly mildly moderately 


















affects my health is what I myself do. 
3 4 5 6 
mildly mildly moderately strongly 
disagree agree agree agree 
If I take care of myself, I can avoid illness. 
1 2 3 4 5 
strongly moderately mildly mildly moderately 




14. When I recover from an illness, it is usually because other people 
(for example, doctors, nurses, family, friends) have been taking 





1 2 3 4 5 
strongly moderately mildly mildly moderately 
disagree disagree disagree agree agree 
No matter what I do, I am likely to get sick. 
1 2 3 4 5 
strongly moderately 
disagree disagree 
mildly mildly moderately 
disagree agree agree 
If it is meant to be, I will stay healthy. 
1 2 3 4 5 
strongly moderately mildly mildly moderately 
disagree disagree disagree agree agree 
If I take the right acti6ns, I can stay healthy. 
1 2 3 4 5 
strongly moderately mildly mildly moderately 

















my health, I can only do what my doctor tells me to do. 
2 3 4 5 6 
moderately mildly mildly moderately strongly 
disagree disagree agree agree agree 
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APPENDIX 8 
SCORING PROCEDURE OF 
HEALTH LOCUS OF CONTROL ITEMS WITHIN M.H.L.C. SCALES 
(FORM A) 
Scale Items 
Internal HLC 1, 6, 8, 12, 13, 17 
Powerful others HLC 3, s, 7, 10, 14, 18 
Chance HLC 2, 4, 9, 11, 15, 16 
Add the raw scores of each of the three dimensions, then 
calculate a standardized score for each raw score. The 
highest standardized score indicates the health locus of 
control held by the individual. 
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